RESEARCH ARTICLE
www.advancedscience.com
AReÔ¨ÅnedAdaptiveLaboratoryEvolutionStrategyWith
Biosensor-AssistedSelectionResolvesthe
Tolerance‚ÄìEÔ¨ÉciencyTrade-OÔ¨ÄinToxicChemical
Biosynthesis
Yufei Zhang, Junhua Yun, Guoyan Zhang, Hossain M. Zabed, Yuehui Tian, Xinrui Tang,
Jia Li, and Xianghui Qi*
Enhancingmicrobialtolerancetotargetchemicalsthroughconventional
adaptivelaboratoryevolution(ALE)istime-consuming,labor-intensive,and
furtherconstrainedbythechallengeofbalancingimprovedtolerancewith
maintainingoptimalbiosyntheticeÔ¨Éciency.Here,thisworkproposesa
reÔ¨ÅnedALEstrategythatcombinesinitialmutagenesiswithanautomated
microdropletcultivation(MMC)system,therebyexpeditingtheacquisitionof
tolerancephenotypes.Integratingabiosensor-assistedhigh-throughput
screeningplatformenablesidentiÔ¨Åcationofstrainsexhibitingadvantageous
‚Äúwin-win‚Äùphenotypes,characterizedbysimultaneousimprovementsinboth
toleranceandbiosyntheticcapacity.Using E. coli forthebiosynthesisof
3-hydroxypropionicacid(3-HP)asamodelsystem,thisworkrapidlyevolves
strainscapableoftolerating720mM3-HPwithin12days.Leveraginganewly
developedandvalidated3-HP-responsivebiosensor,thisworkeÔ¨Éciently
screensandisolatessuperiorstrains.Thetop-performingstrainproduced
86.3gL ‚àí1 3-HPwithayieldof0.82molmol ‚àí1 glycerol.Transcriptomic
analysisprovideinsightsintomechanismsunderlyingthis‚Äúwin-win‚Äù
phenotype.Collectively,thisstudyestablishesaneÔ¨ÄectiveALEframeworkfor
acceleratingthedevelopmentofmicrobialchassistailoredforhigh-eÔ¨Éciency
biochemicalproduction.
Y.Zhang,J.Yun,G.Zhang,H.M.Zabed,Y.Tian,X.Tang,J.Li,X.Qi
InnovativeCenterofCellSignalingTransductionandSynthetic
Biology,GuangdongProvincialKeyLaboratoryofPlantAdaptationand
MolecularDesign,SchoolofLifeSciences
GuangzhouUniversity
230WaiHuanXiRoad,Guangzhou,Guangdong510006,P.R.China
E-mail:qxh@gzhu.edu.cn,qxh@ujs.edu.cn
Y.Zhang,X.Tang,X.Qi
SchoolofFoodandBiologicalEngineering
JiangsuUniversity
301XuefuRoad,Zhenjiang,Jiangsu212013,P.R.China
The ORCID identiÔ¨Åcation number(s) for the author(s) of this article
canbefoundunder https://doi.org/10.1002/advs.202507740
¬©2025TheAuthor(s).AdvancedSciencepublishedbyWiley-VCH
GmbH.Thisisanopenaccessarticleunderthetermsofthe Creative
CommonsAttribution License,whichpermitsuse,distributionand
reproductioninanymedium,providedtheoriginalworkisproperlycited.
DOI:10.1002/advs.202507740
1.Introduction
Biomanufacturing chemicals using micro-
bial cell factories has emerged as a sus-
tainable and promising alternative to con-
ventionalpetrochemicalsynthesis,aligning
more closely with the principles of green
chemistry and sustainable development.[1]
Over the past decades, metabolic engineer-
ing has played a pivotal role in enhancing
the eÔ¨Éciency of microbial chemical pro-
duction, resulting in engineered microor-
ganisms currently utilized in industrial-
scale processes.[2,3] However, despite sig-
niÔ¨Åcant advancements, relying solely on
metabolic engineering to rewrite and op-
timize the primary metabolism of chas-
sis cells often falls short of achieving eco-
nomically viable titers, rates, and yields
(TRY).[4] This shortfall is primarily due to
physiological constraints inherent to mi-
crobial chassis that impede Ô¨Ånely tuned
biosynthetic pathways.[5] One major con-
straint is the limited tolerance of micro-
bialhoststoendproducts,suchasbiofuels
and other biochemicals.[6‚Äì9] As these products accumulate, they
exert stress on the cells, adversely aÔ¨Äecting cellular Ô¨Åtness and
growth, which ultimately restricts overall production TRY.[10]
Overcomingtolerancechallengesisthereforeessentialtounlock-
ingthefullpotentialofmicrobialcellfactoriesandachievingin-
dustriallyrelevantproductionlevels. [11]
Inprinciple,microbialchassiswithenhancedtolerancetospe-
ciÔ¨Åc compounds could be rationally designed based on prior
knowledge. However, in practice, this process is rarely straight-
forwardduetothecomplexityofmicrobialmetabolicandregula-
torynetworks.Alternatively,adaptivelaboratoryevolution(ALE),
anon-rationalengineeringstrategythatsimulatesnaturalevolu-
tionaryprocesses,iswidelyusedtoachieverobusttolerancephe-
notypes. ALE has proven eÔ¨Äective in enhancing host microbial
tolerance to compounds such as 1,3-propanediol,[10] ferulate,[12]
and isobutyl acetate,[13] demonstrating its eÔ¨Äectiveness in cer-
tain contexts. Despite its successes in many applications, tradi-
tionalALEhasnotablelimitations.Typically,ALEbeginswiththe
pure culture of a wild-type microbial host as the starting point
Adv. Sci.2025,12,e07740 e07740(1of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
for evolutionary processes.[14] However, microorganisms inher-
ently exhibit low spontaneous mutation rates, which can signif-
icantly extend the time required to observe meaningful pheno-
typicchanges.[15] Theselowspontaneousmutationratescanalso
resultinevolutionaryfailurewhendesiredhigh-tolerancestrains
are not obtained. Consequently, the ALE process often becomes
exceptionally time-consuming and labor-intensive to carry out
eÔ¨Äectively.[16]
Moreover,theultimategoalofeÔ¨Äectivetoleranceengineering
is not only to enhance microbial resilience under high chemi-
calconcentrationsbutalsotosustainhighproductionmetrics. [11]
Complicatingmattersfurther,alleviatinggrowthinhibitiondoes
notnecessarilyleadtoincreasedproduction.Thisparadoxarises
because, when encountering high product toxicity or environ-
mentalstress,microorganismsmayredistributeinternalenergy
and resources to prioritize survival over production.[17] For in-
stance, cells with increased tolerance may allocate more energy
towardprotectivemechanismssuchasmembranerepair,antiox-
idantdefenses,andtheexpressionofanti-stressproteins. [18] This
reallocationcandiminishtheenergyandresourcesavailablefor
metabolicpathwaysresponsibleforsynthesizingthetargetprod-
uct,leadingtodecreasedproduction. [19] Asaresult,althoughen-
hancedtolerancesupportssurvival,theaddedmetabolicburden
mayhindertheoverallproductivityofthebioprocess.
To overcome the limitations of traditional ALE in tolerance
engineering, we propose a reÔ¨Åned strategy designed to acceler-
ate and streamline the evolution process while overcoming the
trade-oÔ¨Ä between enhanced tolerance and sustained production
capabilities. Instead of initiating ALE with a wild-type pure cul-
ture,ourapproachemploysamutagenizedmicrobiallibrary,in-
troducingrandomgenomicmutationstocreateadiversepoolof
geneticvariants.ThisartiÔ¨Åcialenhancementofgeneticdiversity
canincreasethelikelihoodofbeneÔ¨Åcialmutationsbeingpresent
withintheinitialpopulation,enablingnaturalselectiontoactim-
mediately on advantageous variants without relying on the oc-
currence of spontaneous mutations. By eÔ¨Äectively ‚Äúpreloading‚Äù
thepopulationwithawidespectrumofgeneticpossibilities,this
strategyisexpectedtoimprovetheprobabilityofevolvingstrains
capableofthrivingunderselectivepressures,therebyenhancing
the eÔ¨Éciency of the ALE process. Additionally, we integrate this
mutagenized library with an automated microbial microdroplet
culture(MMC)systemandincorporatehigh-throughputscreen-
ing techniques.[20] The MMC system enables high-throughput
cultivation of microorganisms within microliter-scale droplets,
substantially improving the scalability and eÔ¨Éciency of ALE
experiments while minimizing resource consumption. Beyond
high-throughput cultivation, the system integrates multiple au-
tomated functions, including serial passaging, real-time optical
density monitoring, gradient-based addition of chemical stres-
sors, and programmable droplet sorting for the isolation of tar-
get subpopulations. This miniaturized, closed-loop platform re-
duces reagent usage, manual workload, and contamination risk
whileenablinghigh-throughput,precise,long-termadaptiveevo-
lution. Furthermore, high-throughput screening technology is
employedtoidentifymutantsthatnotonlyexhibitimprovedtol-
erance but also maintain or enhance production performance.
Thisintegrationofmutagenizedlibraries,automatedcultivation,
and high-throughput screening signiÔ¨Åcantly reduces the time
andeÔ¨ÄorttypicallyrequiredforALE,whileincreasingthelikeli-
hoodofdiscovering‚Äúwin-win‚Äùchassisthatcombinerobuststress
tolerance with superior production capabilities. Through this
comprehensive and eÔ¨Écient strategy, we aim to overcome the
challengesoftraditionalALEandadvancetoleranceengineering
inmicrobialsystems.
Here, as a proof-of-concept, we focused on the tolerance en-
gineering ofEscherichia coli to enhance the biosynthesis of 3-
hydroxypropionicacid(3-HP),servingasanexampletotestand
validateourproposed strategy. Wechose3-HPbiosynthesisdue
to its designation as one of the 12 high-value platform chem-
icals by the U.S. Department of Energy (DOE) and its signiÔ¨Å-
cant industrial potential.[21] However, the inherent toxicity of 3-
HP to microbial hosts has posed a critical challenge to achiev-
ing eÔ¨Écient production.[22] SpeciÔ¨Åcally, we performed in vivo
mutagenesis (IVM) to generate a diverse genetic library ofE.
coli W3110,[23] which served as the starting point for ALE in
the MMC system. Through this approach, the evolution pro-
cess was signiÔ¨Åcantly accelerated and simpliÔ¨Åed. Furthermore,
abiosensor-assistedhigh-throughputscreeningplatformwases-
tablished and utilized to identify individuals with superior pro-
ductioneÔ¨Éciencyfromtheevolvedpopulations.Notably,weob-
tained strains with the ‚Äúwin-win‚Äù phenotype, characterized by a
balance between increased tolerance and improved production
capacity. Through transcriptomic sequencing, we also revealed
the mechanisms contributing to enhanced 3-HP tolerance and
biosynthesiscapacity,providinginsightsintothegeneticandreg-
ulatory changes involved. In summary, our study presents a re-
Ô¨Åned strategy that integrates IVM-coupled ALE and biosensor-
assistedselectiontoresolvethetrade-oÔ¨Äbetweenmicrobialtoler-
anceandproductioneÔ¨Éciency.Thisapproachnotonlyaddresses
the limitations of traditional ALE but also oÔ¨Äers an adaptable
frameworkforengineeringmicrobialchassisfortheeÔ¨Écientpro-
ductionofothervaluablebiochemicals,particularlyusingthever-
satileE.coli platform.
2.Results
2.1.MetabolicEngineeringofthe3-HPBiosyntheticPathway
Pathway engineering for 3-HP biosynthesis is a crucial founda-
tion for subsequent tolerance engineering eÔ¨Äorts. As an initial
step, we focused on establishing a functional 3-HP biosynthetic
pathway. To this end, a tailored chassis, designated as TD, was
constructed by deleting multiple genes (adhE, pÔ¨ÇB, ldhA, poxB,
pta-ackA,a n dyqhD)i nE. coliW3110 (Figure 1a). These dele-
tions targeted pathways responsible for the synthesis of major
by-products, such as ethanol, formate, lactate, acetate, and 1,3-
propanediol,[21] with the goal of minimizing by-product accu-
mulation and streamlining metabolic Ô¨Çux toward 3-HP produc-
tion (Figure1a). The 3-HP biosynthetic pathway was recruited
into chassis TD through the heterologous expression of key en-
zymes derived fromKlebsiella pneumoniae, speciÔ¨Åcally glycerol
dehydratase (GDHt, encoded bydhaBCE), its activator (GDR,
encoded bygdrAB), andùõæ-aminobutyraldehyde dehydrogenase
(ALDH,encodedby KpydcW).[22] Additionally,theglycerolfacili-
tator(GlpF,encodedby glpF)wasoverexpressedtoimproveglyc-
erol uptake (Figure1a). The constitutive promoters tac and trc
wereemployedtodrivetheexpressionofthe dhaBCE-gdrAB-glpF
cassette andKpydcW gene, respectively (Figure1b). This design
Adv. Sci.2025,12,e07740 e07740(2of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
Figure 1.Metabolic engineering ofE. coliW3110 for enhanced biosynthesis of 3-HP from glycerol. a) Schematic illustration of the rewired metabolic
pathway inE. colichassis TD for 3-HP biosynthesis from glycerol. b) Genetic maps of plasmid constructs. Plasmid 1 (pORI1-dhaBCE-gdrAB-glpF)e n -
codes the upstream module that converts glycerol to 3-HPA, while Plasmid 2 (pORI2-KpydcW) encodes an aldehyde dehydrogenase that catalyzes the
downstreamconversionof3-HPAto3-HP.c,d)Final3-HPtiteranddrycellmass(DCM)ofengineeredstrainsTDS1toTDS10after48hofcultivationin
modiÔ¨ÅedM9mediumcontaining10gL ‚àí1 glycerol,25 ŒºMvitaminB 12,25 ŒºgmL‚àí1 chloramphenicol,and50 ŒºgmL‚àí1 kanamycin(n=3).e)Time-course
proÔ¨Åle of 3-HP titer, residual glycerol, 3-HPA, and DCM during 48 h fermentation of strain TD S6 under the same cultivation conditions (n = 3). Data
are presented as mean¬± SD from independent biological replicates. Statistical signiÔ¨Åcance was determined using a two-tailed Student‚Äôst-test, **p <
0.01.(a,b)werecreatedinBioRender.Zhang,Y.(2025) https://BioRender.com/pfubzkv,andlicensedforpublication.
enabled the engineered strain to convert glycerol into the inter-
mediate3-hydroxypropionaldehyde(3-HPA)viaGDHt,andthen
into3-HPthroughALDH(Figure 1a).Co-expressionofGDRsus-
tainedGDHtactivity,therebyenhancingtherobustnessandeÔ¨É-
ciencyof3-HPbiosynthesis. [24]
It is important to emphasize that 3-HPA is highly cytotoxic,
and its accumulation can severely impair cell growth and en-
zyme activity, ultimately reducing 3-HP production.[25] There-
fore,ratherthansimplyincreasingtheexpressionofbothGDHt
and ALDH, it is essential to achieve an appropriate balance be-
tweenthesetwoenzymestopreventtoxicbuildupof3-HPAwhile
ensuring eÔ¨Écient biosynthesis of 3-HP. To accomplish this, we
integrated the tac-dhaBCE-gdrAB-glpF and trc-KpydcW expres-
sion cassettes into plasmids with varying copy numbers. By
strategicallyconÔ¨ÅguringdiÔ¨Äerentplasmidcombinations(Figure
S1a, Supporting Information), we Ô¨Åne-tuned the 3-HP biosyn-
thetic pathway in chassis TD, constructing a total of 10 engi-
neered strains (TD S1‚ÄìTD S10). These strains were subjected
to shake-Ô¨Çask fermentation in modiÔ¨Åed M9 medium supple-
mentedwith10gL ‚àí1 glycerol.Amongthesestrains,TDS6exhib-
itedsuperioreÔ¨Éciencyin3-HPproduction(Figure 1c‚Äìe),achiev-
ing a titer of 5.13 g L‚àí1 with negligible accumulation of 3-HPA
(FigureS1b,SupportingInformation).Thus,theplasmidconÔ¨Åg-
uration, comprising p15A-tac-dhaBCE-gdrAB-glpF and pBR322-
trc-KpydcW,harboredbyTDS6,wasselectedforfurtherapplica-
tions.
2.2.ToleranceEngineeringofChassisTDthroughaReÔ¨ÅnedALE
Strategy
To enhance the 3-HP tolerance of chassis TD, we adopted the
reÔ¨Åned ALE strategy. This approach involves utilizing a mutag-
enized microbial library as the initial population for ALE, pro-
moting genetic diversity. The increased diversity allows natural
selection to act immediately on advantageous variants without
relyingsolelyonspontaneousmutations,therebyfacilitatingthe
rapid acquisition of a highly tolerant phenotype. IVM technol-
ogy,selectedforitsbroad-spectrumapplicabilityandoperational
simplicity, was employed to construct the mutagenized micro-
bial library based on chassis TD. SpeciÔ¨Åcally, we employed the
plasmid-based IVM system MP6,[23] which was further modi-
Ô¨Åed by replacing its original replicon with the thermo-sensitive
replicon pSC101(ts). This modiÔ¨Åcation led to the generation of
Adv. Sci.2025,12,e07740 e07740(3of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
pTSMP6,aplasmidcapableofeÔ¨ÉcientcuringfollowingtheIVM
process.Subsequently,pTSMP6wasintroducedintoTDpriorto
mutagenesis. After induction with L-arabinose to trigger unsta-
blereplicationofthegenome,apopulationwithgeneticdiversity
wasgenerated.Byexploitingthehigh-temperature-inducedinsta-
bilityoftherepliconpSC101(ts),wecuredpMP6tsandobtained
the mutagenized microbial library derived from TD, designated
asTD-MUT,forsubsequentALEexperiments( Figure2a).
To increase microbial cultivation throughput and reduce re-
liance on manual labor, we employed the automated, high-
throughput MMC system to facilitate the ALE process.[20] Con-
sidering the distinct diÔ¨Äerences between the MMC system and
traditional shake Ô¨Çask cultivation in terms of cultivation modes
andopticaldensitymeasurementmethods,weÔ¨Årstassessedthe
3-HPtoleranceofthechassisstrainTDwithintheMMCsystem
to ensure its suitability. This evaluation was conducted using a
‚Äúsingle-factor,multi-level‚Äùexperimentalframework,where3-HP
concentrationwassetasthesolevariableandtestedacrossmul-
tiple levels (0, 180, 360, 540, and 720 mM). In this context, con-
centrationswereexpressedin‚ÄúmM‚Äùunitstofacilitateconvenient
dilutionfroma3.6Mcommercial3-HPstocksolutionandtoen-
sureprecisecontrolduringALEexperiments.Forreference,the
tested concentrations of 180, 360, 540, and 720 mM correspond
to‚âà15.8,31.6,47.4,and63.2gL ‚àí1,respectively.UndertheMMC
system, the growth of TD was signiÔ¨Åcantly inhibited when the
concentration of 3-HP reached 360 mM (p < 0.001), and nearly
ceased at concentrations above 540 mM (Figure2b). These ob-
servationswereconsistent withtheresultsobtainedfromshake
Ô¨Çask cultivation (FigureS2, Supporting Information), aÔ¨Érming
theMMCsystemasareliableplatformforfacilitatingtheevolu-
tionof3-HPtolerance.
Subsequently,TD-MUTwasemployedastheinitialpopulation
fortheALEprocess.Usingthe‚Äúadaptiveevolution‚Äùfunctionality
oftheMMCsystem,TD-MUTunderwent3-HPtoleranceevolu-
tionthroughautomatedserialpassagingandcontinuouscultiva-
tion (Figure2a). To maximize throughput, 50 microdroplet cul-
tivation units (droplets 1‚Äì50) were established within the MMC
system, functioning as the equivalent of 50 parallel shake-Ô¨Çask
cultures.Thesedropletswereactivatedthroughasinglegenera-
tionofcultivation in amediumwithout 3-HPandsubsequently
transferredtomediawithprogressivelyincreasing3-HPconcen-
trationstoinitiateevolution.The3-HPconcentrationwasincre-
mentally raised from 90 to 720 mM in 90 mM steps, with three
passagesperformedateachconcentrationleveltoallowsuÔ¨Écient
adaptation.Theentireevolutionprocesslasted12days,withthe
growth curves of individual microdroplets shown in Figure2c.
During the activation phase of cultivation, in the absence of 3-
HP, all droplets exhibited generally favorable growth. However,
notablevariationsingrowthperformancewereobservedamong
droplets.Sinceweusedamutagenizedlibraryratherthanapure
culture as the starting point for evolution, the observed diÔ¨Äer-
ences can be attributed to the distinct genetic characteristics of
thecellpopulationswithinindividualdroplets,originatingfrom
TD-MUT. During the subsequent evolution phase, as the selec-
tionpressurefrom3-HPprogressivelyincreased,thegrowthpat-
terns among the droplets diverged further, particularly within
the concentration range of 270 to 450 mM. Notably, this diver-
gencewasmostevidentindropletssuchasdroplet31anddroplet
19, where cells were unable to withstand the pressure and per-
ishedentirelywhenthe3-HPpressurereached360mM(Figure
S3, Supporting Information). Such a pronounced divergence in
growth trends is rarely observed when ALE is performed using
pure cultures.[26] Interestingly, as the 3-HP concentration fur-
therincreasedto630mM,thediÔ¨Äerentiationingrowthpatterns
among the surviving droplets became diminished. This obser-
vation suggests that during the ALE process, as selective pres-
sureintensiÔ¨Åed,cellpopulationsharboringbeneÔ¨Åcialmutations
for3-HPtolerancemanagedtosurviveandgraduallydominated
withinthesurvivingdroplets.Consequently,thecellsinthesur-
viving droplets acquired superior 3-HP tolerance and exhibited
more stabilized growth patterns. After 12 days of ALE, the sur-
viving droplets exhibited markedly enhanced tolerance to 3-HP,
demonstrating the ability to sustain growth under the selective
pressureof720mM3-HP.
2.3.Evaluationof3-HPToleranceandBiosynthesisPerformance
During the Ô¨Ånal stage of adaptation to the 720 mM 3-HP gradi-
ent,theOD MMC (opticaldensitywithintheMMCsystem)values
of the surviving droplets ranged from 2.05 to 3.70 (Figure2d).
Notably,droplets2,1,and5exhibitedthehighestOD MMC values.
These droplets were subsequently extracted from the MMC sys-
tem for further propagation and detailed characterization. The
growthofdroplets2,1,and5wasinitiallyevaluatedinmodiÔ¨Åed
M9mediumcontaining720mM3-HPundershakeÔ¨Çaskcondi-
tions. The results revealed that all three droplets displayed nor-
mal growth with similar growth trends, among which droplet 2
showed a slight growth advantage (Figure2e). To further study
thepropertiesofdroplet2,itscultivationwasdilutedandplated
to isolate individual colonies. Nine colonies, randomly selected
and designated as RAND1‚ÄìRAND9, were characterized in de-
tail to assess their 3-HP tolerance and production capabilities.
Growth assessments revealed that all tested colonies were ca-
pable of growing under 720 mM 3-HP conditions (Figure2f).
The Ô¨Ånal biomass of the tested colonies, reÔ¨Çected as a dry cell
mass (DCM) of‚âà0.6 g L‚àí1, was lower than the 1.0 g L‚àí1 ob-
served in the absence of 3-HP (FigureS4, Supporting Informa-
tion).Nevertheless,thisresultrepresentedasigniÔ¨Åcantimprove-
ment(p<0.001)comparedtothecompletegrowthinhibitionex-
hibitedbytheinitialchassisTDunder720mM3-HPconditions
(Figure2f).TheseÔ¨Åndingssuggestedthatcellindividualsderived
fromdroplet 2 successfully acquired thedesired 3-HPtolerance
phenotypethroughIVM-coupledALE.
Subsequently, the previously constructed 3-HP biosynthetic
pathway was introduced into the isolated 3-HP-tolerant chas-
sis(RAND1‚ÄìRAND9),resultinginstrainsdesignatedasRAND1
S6‚ÄìRAND9S6.Toassessthe3-HPbiosynthesisperformanceof
these strains, fermentations were carried out in modiÔ¨Åed M9
medium containing 10 g L‚àí1 glycerol, using strain TD S6 as a
control. The fermentation results, as shown in Figure2g,r e -
vealedsigniÔ¨Åcantvariationin3-HPproductionamongthestrains
(F(8, 18)= 61.71, p < 0.001), with titers ranging from 2.73 to
5.70 g L‚àí1. Surprisingly, most strains failed to show signiÔ¨Åcant
improvementin3-HPproductioncomparedtothecontrol,with
only RAND7 S6 achieving a notable 11.11% increase (p < 0.05).
Among the other strains, 5 showed no signiÔ¨Åcant changes (p >
0.05),whilethreeexhibitedmarkedlyreducedproduction.Inpar-
Adv. Sci.2025,12,e07740 e07740(4of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
Figure2. Enhancing3-HPtoleranceofchassisTDthroughIVMandMMC-basedadaptiveevolution.a)SchematicworkÔ¨ÇowoftheIVMandMMC-based
adaptive evolution process. Step I: A mutagenized microbial library was constructed via plasmid pTSMP6-mediated IVM. Step II: The resulting library
was subjected to adaptive evolution using MMC system. In this system, bottle B0 contained the carrier oil phase; B1 and B2 supplied modiÔ¨Åed M9
medium without and with 720 mM 3-HP, respectively; B3 held the initial mutagenized population; and B4 served as the waste reservoir. b) Sensitivity
analysisofchassisTDundervaryingconcentrationsof3-HPintheMMCsystem( n=5).c)Dynamicgrowthperformanceof50individualdropletsover
Adv. Sci.2025,12,e07740 e07740(5of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
ticular, RAND2 S6 exhibited the lowest 3-HP titer at 2.73 g L‚àí1,
representing a 46.78% decrease compared to TD S6. The varia-
tion in 3-HP biosynthetic performance suggested that, even af-
terALE,thecellpopulationindroplet2remainedgeneticallydi-
verse, consisting of cells with varying traits. As the evolutionary
direction of ALE targeted 3-HP tolerance exclusively, most cells
inthispopulationacquiredgeneticmutationsthatimprovedtol-
erance rather than enhancing production. Additionally, certain
mutations may inadvertently disrupt key metabolic pathways or
regulatorynetworks,potentiallyimpairing3-HPsynthesis.These
might account for the observed variations in 3-HP production
amongthestrains(RAND1S6‚ÄìRAND9S6).
Theaforementionedobservationsdemonstratedthecomplex-
ity of engineering microbial chassis to simultaneously achieve
robusttoleranceandeÔ¨Écientbiosyntheticperformance,indicat-
ing the necessity of balancing enhanced tolerance with biosyn-
thetic eÔ¨Éciency. Since IVM can generate a broad spectrum of
mutations,itisplausiblethatsomecellsindroplet2mayexhibit
phenotypesforboth3-HPtoleranceandhighproductionconcur-
rently.Giventhatthecellsindroplet2alreadydisplayeda3-HP-
tolerant phenotype, our subsequent eÔ¨Äorts will therefore priori-
tize high-throughput screening of these individuals in droplet 2
to identify cells exhibiting a ‚Äúwin-win‚Äù phenotype characterized
bybothhigh3-HPtoleranceandelevatedproduction.
2.4.DesignandModulationofa3-HP-ResponsiveBiosensor
Due to the lack of tailored tools for high-throughput detection
of3-HPinmicrobialfermentationsystems,innovativesolutions
areneeded. Developing biosensors that can speciÔ¨Åcally respond
to target metabolites and translate signals into measurable out-
puts, such as Ô¨Çuorescence or luminescence, oÔ¨Äers a promising
approachforestablishinghigh-throughputscreeningplatforms.
Accordingly,weaimedtodesignandconstructa3-HPresponsive
biosensortofacilitatetheidentiÔ¨Åcationof‚Äúwin-win‚Äùchassiswith
bothenhanced3-HPtoleranceandelevatedproductioncapacity.
2.4.1. IdentiÔ¨Åcation of a 3-HP Responsive Genetic Element
In H. bluephagenesis, the addition of 3-HP has been reported
to activate a 3-HP degradation pathway involving two genes,
GME_RS01255 and GME_RS01260.[27] This activation, speciÔ¨Å-
callyinducedby3-HP,suggeststheexistenceofgeneticelements
in H. bluephagenesis that response to 3-HP. These elements
could be harnessed for the development of a 3-HP-responsive
biosensor. Genome analysis revealed thatGME_RS01255 and
GME_RS01260 are located adjacent to each other and share a
common promoter, hereafter referred to as PhpTD (Figure S5,
Supporting Information). Interestingly, upstream of these two
genes,anothergeneannotatedasaLysR-familytranscriptionfac-
tor (LysR-TF), GME_RS01250 (hereafter referred to as HPTDR,
with its encoding gene designated ashpTDR), was identiÔ¨Åed
(Figure3a).Notably,thisgeneistranscribedintheoppositedirec-
tionto GME_RS01255andGME_RS01260,indicatingaclosege-
neticassociationandpotentialregulatoryinteraction(Figure 3a).
LysR-TFs typically regulate genes involved in metabolism,
stressresponses,andbiosynthesisthroughsmall-moleculebind-
ing and conformational changes that control their activities.[28]
Basedonthis,wehypothesizedthatHPTDRfunctionsasaregu-
latoryprotein.SpeciÔ¨Åcally,weproposethatitactsasarepressor,
regulatingtheexpressionofGME_RS01255andGME_RS01260
in response to the presence or absence of 3-HP. In the ab-
sence of 3-HP, HPTDR is predicted to bind to the PhpTD pro-
moter region, blocking RNA polymerase access and silencing
transcription (Figure3b). Conversely, in the presence of 3-HP,
the molecule is speculated to interact with HPTDR, triggering
a conformational change that reduces its aÔ¨Énity for the PhpTD
promoter. This allows RNA polymerase to access the promoter,
initiating the transcription and activating the 3-HP degradation
pathway(Figure 3b).
To validate this hypothesis, we conducted further bioinfor-
matics analyses of HPTDR and investigated its interaction with
3-HP. Protein family and domain analysis using the InterPro
database conÔ¨Årmed that HPTDR is a typical LysR-TF, featuring
a DNA-binding domain and a substrate-binding domain con-
nectedbyalinkerpeptide(Figure 3c,d).Thisuniquestructuralar-
rangementischaracteristicofLysR-TF,whichregulatesgeneex-
pression by binding to small-molecule ligands.[29] Furthermore,
moleculardockinganalysisrevealedthatthe3-HPformshydro-
gen bond interactions with several amino acid residues in the
substrate-bindingdomainofHPTDR,includingVal100,Ser130,
and Ala203 (Figure3e). Together, these residuals form a stable
binding pocket, ensuring the positioning of 3-HP. This interac-
tionlikelytriggersaconformationalchangeinHPTDR,leading
toitsdissociationfromP hpTD.TheseÔ¨Åndingssupportourhypoth-
esis andsuggest thatHPTDRand itsregulatorypromoterP hpTD
canserveasapotentialcandidateforthedevelopmentofa3-HP-
responsivebiosensor.
2.4.2. Design and Validation of a 3-HP-Responsive Biosensor
To construct a functional 3-HP-responsive biosensor, we em-
ployedtheconstitutivepromoterJ23129todrivetheexpressionof
thehpTDRgene.ThisgeneencodestheHPTDRprotein,which
servesasakeyregulatorycomponent.ThegreenÔ¨Çuorescentpro-
tein genesfGFP, under the control of the regulatory promoter
300 h under incremental 3-HP stress. d) Final optimal density (ODMMC) of 50 individual droplets after the ALE process. e) Shake-Ô¨Çask growth curve
of selected droplets (droplet 1, 2, and 5) cultivated in modiÔ¨Åed M9 medium supplemented with 720 mM 3-HP (n = 3). f) Final biomass (DCM) and
3-HP production of 9 randomly selected single colonies derived from droplet 2, with the parental chassis TD used as a control. Strains were cultivated
in modiÔ¨Åed M9 medium containing 720 mM 3-HP for 48 h (n = 3). g) 3-HP production of 9 isolates derived from droplet 2 after introduction of the
3-HP biosynthetic pathway, with strain TD S6 used as the control. Strains were cultivated in modiÔ¨Åed M9 medium containing 10 g L‚àí1 glycerol, 25ŒºM
vitaminB12,25 ŒºgmL‚àí1 chloramphenicol,and50 ŒºgmL‚àí1 kanamycinfor48h( n= 3).Dataarepresentedasmean ¬± SDfromindependentbiological
replicates.Fortwo-groupcomparison,statisticalsigniÔ¨Åcancewasdeterminedusingatwo-tailedStudent‚Äôs t-testagainstthecontrolgroup,*** p<0.001,
*p< 0.05.Formultiple-groupcomparison,statisticalsigniÔ¨Åcancewasdeterminedusingaone-wayANOVA.(a)CreatedinBioRender.Zhang,Y.(2025)
https://BioRender.com/vsoqa9m,andlicensedforpublication.
Adv. Sci.2025,12,e07740 e07740(6of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
Figure 3. IdentiÔ¨Åcation, design, and optimization of a 3-HP-responsive biosensor. a) Genomic arrangement ofGME_RS01255, GME_RS01260,a n d
GME_RS01250 in H. bluephagenesis. b) Proposed regulatory mechanism of HPTDR under the control of the PhpTD promoter, showing transcriptional
repression in the absence and derepression in the presence of 3-HP. c) Domain architecture of HPTDR, consisting of an N-terminal DNA-binding
domain (Domain I) and a C-terminal substrate-binding domain (Domain II). d) Predicted 3D structure of HPTDR, with DNA-binding and substrate-
bindingregionsindicated.e)Detailedviewofthesubstrate-bindingpocketandkeyaminoacidresiduespredictedtointeractwith3-HP.f)Plasmidm ap
of the 3-HP biosensor (pSEN T0). g) Schematic illustration of the biosensor mechanism: in the absence of 3-HP, HPTDR binds to the promoter and
repressestranscription(OFFstate);upon3-HPbinding,repressionisrelieved,leadingtosfGFPexpression(ONstate).h)Performanceofthebiose nsor
inresponsetovaryingconcentrationsof3-HP,measuredasspeciÔ¨ÅcÔ¨ÇuorescenceinSenPOSI,SenT0,andSenNEGA.Thebiosensorcellswerecultured
inmodiÔ¨ÅedM9mediumsupplementedwith10gL ‚àí1 glyceroland25 ŒºgmL‚àí1 chloramphenicolinmicrotiterplatesfor9h( n=3).i)SpeciÔ¨ÅcÔ¨Çuorescence
anddynamicrangeofbiosensorvariantsharboringdiÔ¨ÄerentRBScombinations( n=3).j)Dose-responsecurveoftheoptimizedbiosensor(pSENT6),
showing a strong positive correlation between 3-HP concentration and speciÔ¨Åc Ô¨Çuorescence (n = 3). k) SpeciÔ¨Åcity analysis of the biosensor SEN T6
in response to 3-HP and other analogs (n = 3). Data are presented as mean¬± SD from independent biological replicates. Statistical signiÔ¨Åcance was
determined using a two-tailed Student‚Äôst-test, ***p < 0.001. (b,f,g) were treated in BioRender. Zhang, Y. (2025)https://BioRender.com/o4tr10q,a n d
licensedforpublication.
Adv. Sci.2025,12,e07740 e07740(7of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
PhpTD,servedastheoutputsignalmodule.Theseelementswere
assembledintotheplasmidpSENT0(Figure 3f),withthecorre-
spondingbiosensornamedSENT0.Inthisdesign,a3-HPinput
is expected to be associated with the Ô¨Çuorescence intensity out-
put.Without3-HP,HPTDRrepressesP hpTD-driventranscription,
maintainingthebiosensorinan‚ÄúoÔ¨Ä‚ÄùstatewithminimalÔ¨Çuores-
cence(Figure 3g).Upon3-HPbinding,HPTDRdissociatesfrom
PhpTD, activating transcription and triggering a strong Ô¨Çuores-
cencesignal,representingthe‚Äúon‚Äùstate(Figure 3g).Tovalidate
biosensor functionality, we also constructed two control biosen-
sors:SENNEGA,lackingthe sfGFPgene,andSENPOSI,lacking
thehpTDRgene.SENNEGAcannotproduceÔ¨Çuorescence,serv-
ing as the negative control. SEN POSI, devoid of HPTDR, leads
toconstitutiveactivationofP hpTD andcontinuoussfGFPexpres-
sion,servingasthepositivecontrol.
The Ô¨Çuorescence outputs of SEN T0, SEN NEGA, and SEN
POSIwereevaluatedacrossdiÔ¨Äerent3-HPconcentrations.Spe-
ciÔ¨Åc Ô¨Çuorescence intensity (deÔ¨Åned as the ratio of Ô¨Çuorescence
to biomass) was used to normalize signal output and eliminate
biomass-related variability. As expected, SEN NEGA displayed
negligible speciÔ¨Åc Ô¨Çuorescence intensities, attributable to back-
ground noise from the chassis or system errors (Figure3h).
SEN POSI exhibited consistently high speciÔ¨Åc Ô¨Çuorescence in-
tensities (‚âà20 000 a.u.) across all 3-HP concentrations, consis-
tent with constitutive sfGFP expression due to the absence of
HPTDR repression. SEN T0, in contrast, demonstrated a clear
3-HP-dependent response (Figure3h). SpeciÔ¨Åc Ô¨Çuorescence in-
tensity increased with rising 3-HP concentrations, indicating a
strong positive correlation. Higher 3-HP levels elicited stronger
Ô¨Çuorescence signals, conÔ¨Årming that SEN T0 eÔ¨Äectively senses
3-HP and that HPTDR modulates PhpTD-driven transcription in
responseto3-HPbinding.Thisdose-dependentÔ¨Çuorescencere-
sponse validates the rationality of our biosensor design and un-
derscores its potential application in quantifying environmental
3-HPconcentrations.
2.4.3. Optimization and Characterization of the Designed Biosensor
ThedynamicrangeofabiosensoriscriticalforaccurateandeÔ¨É-
cientdetectionacrossvaryingtargetmoleculeconcentrations. [30]
TooptimizethedynamicrangeofthebiosensorSENT0,weÔ¨Åne-
tuned the expression levels of HPTDR and sfGFP by employ-
ingribosomebindingsites(RBS)withvariousstrengths(B0030,
B0031, and B0032). By combining these RBSs in diÔ¨Äerent con-
Ô¨Ågurations,9biosensorsweredevelopedanddesignatedasSEN
T1‚ÄìSEN T9 (FigureS6, Supporting Information). SpeciÔ¨Åc Ô¨Çuo-
rescenceintensitiesofthesebiosensorswereevaluatedinmedia
containing 0 and 5 g L‚àí1 3-HP. As shown in Figure3i,Ô¨Ç u o r e s -
cence outputs and dynamic ranges diÔ¨Äered among the biosen-
sors, indicating that modulation of HPTDR and sfGFP transla-
tion can profoundly inÔ¨Çuence biosensor performance. Notably,
SEN T6, featuring the B0032-hpTDR and B0030-sfGFP combi-
nation, achieved a dynamic range of 18.03-fold within the 0‚Äì
5gL ‚àí1 3-HPrange,signiÔ¨Åcantlysurpassingtheoriginalbiosen-
sor SEN T0 (9.66-fold;p < 0.001). We further characterized the
optimized biosensor SEN T6 over an expanded 3-HP concen-
tration range (0‚Äì10 g L‚àí1) .A ss h o w ni nF i g u r e3j, speciÔ¨Åc Ô¨Çu-
orescence intensity exhibited a strong linear relationship with
3-HP concentration (1‚Äì10 g L‚àí1). The coeÔ¨Écient of determina-
tion (R2 = 0.979) indicates that SEN T6 enables accurate quan-
titative detection within this range. The speciÔ¨Åcity of SEN T6
was assessed by measuring its response to various 3-HP struc-
tural analogs, including propionate, lactate, malonate, pyruvate,
citrate,ùõº-ketoglutarate,succinate,fumarate,malate,andoxaloac-
etate.SENT6exhibitedhighspeciÔ¨Åcityfor3-HP,withnegligible
responsestoothertestedcompounds(Figure 3k).ThisspeciÔ¨Åcity
suggests the potential of SEN T6 for precise 3-HP detection in
complex fermentation environments without interference from
othermetabolites.
2.5.Biosensor-AssistedHigh-ThroughputSelection
2.5.1. Establishment and Validation of an In Vivo High-Throughput
Platform
The aforementioned experiment preliminarily validated the fea-
sibility of the 3-HP-responsive biosensor through the external
addition of 3-HP in an in vitro setting. However, biosensor re-
sponses to target molecules can diÔ¨Äer between in vitro and in
vivo environments.[31] To further validate the in vivo applicabil-
ity of SEN T6, we integrated the biosensor within strains pro-
ducing intracellular 3-HP. For this purpose, we selected three
chassis, RAND2, RAND4, and RAND7, isolated from droplet 2,
based on their distinct 3-HP production capacities. SpeciÔ¨Åcally,
RAND2 S6 produced 2.72 g L‚àí1 of 3-HP, RAND4 S6 achieved
4.18gL ‚àí1,andRAND7S6reached5.70gL ‚àí1,categorizingthem
as low-production (LowProd), medium-production (MedProd),
and high-production (HighProd) chassis, respectively. To evalu-
atewhetherthebiosensorcoulddiÔ¨Äerentiatestrainswithvarying
3-HPproductionlevels,thebiosensormodulefromSENT6was
integrated into the plasmid p15A-tac-dhaBCE-gdrAB-glpF,g e n -
erating p15A-tac-dhaBCE-gdrAB-glpF-SENSOR (Figure4a). This
plasmid, along with pBR322-trc-KpydcW, was co-transformed
into RAND2, RAND4, and RAND7, resulting in strains HP-
LowProd,HP-MedProd,andHP-HighProd,respectively.
We Ô¨Årst assessed the production characteristics of HP-
LowProd,HP-MedProd,andHP-HighProdbyconductingshake-
Ô¨Çask fermentations and measuring the Ô¨Ånal 3-HP titers after
48 h. The results conÔ¨Årmed that all three strains exhibited 3-
HPproductionlevelscomparabletothoseoftheircorresponding
parentalstrainslackingthebiosensormodule(Figure 2g;Figure
S7,SupportingInformation).Toevaluatewhetherthebiosensor
signals in microplates could reÔ¨Çect the Ô¨Ånal 3-HP titers, and to
determinewhichtimepointprovidedthemostaccuratecorrela-
tion, we measured the speciÔ¨Åc Ô¨Çuorescence intensities of these
strains at 3, 9, 15, and 21 h. It was shown that all four time
points demonstrated a positive correlation between speciÔ¨Åc Ô¨Çu-
orescence intensities and Ô¨Ånal 3-HP titers (FigureS8, Support-
ing Information). Notably, the 9-h measurement exhibited the
strongest correlation (R = 0.967, p < 0.0001), indicating that
biosensoroutputatthisstagecanmostaccuratelyreÔ¨ÇecttheÔ¨Ånal
production level (Figure4b). In comparison, the 3, 15, and 21 h
timepointsallexhibitedweakercorrelations(Figure S8,Support-
ingInformation).Thereducedcorrelationat3hwaslikelydueto
insuÔ¨Écientproductaccumulation,whichlimitedbiosensoracti-
vation.Incontrast,thelowercorrelationsobservedat15and21h
Adv. Sci.2025,12,e07740 e07740(8of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
Figure4. Biosensor-assistedidentiÔ¨Åcationandcharacterizationofsuperior3-HP-producingstrainsderivedfromdroplet2.a)Schematicillustrationof
the biosensor-assisted screening system, integrating genetic cassettes for 3-HP biosynthesis and Ô¨Çuorescence-based sensing. b) Correlation between
speciÔ¨Åc Ô¨Çuorescence and Ô¨Ånal 3-HP titers of three representative strains (HP-LowProd, HP-MedProd, and HP-HighProd). Final 3-HP titers were deter-
minedfrom48hshake-Ô¨Çaskfermentations,whilespeciÔ¨ÅcÔ¨Çuorescenceintensitiesweremeasuredat3,9,15,and21hfrommicroplatecultures( n=3).
c) Diagrammaticoverview of the workÔ¨Çow for the biosensor-assistedscreening. d) Fold changein speciÔ¨Åc Ô¨Çuorescence intensityrelativeto thecontrol
strainHP0000among1045candidatestrains(HP0001‚ÄìHP1045).StrainswerecultivatedinmodiÔ¨ÅedM9mediumsupplementedwith10gL ‚àí1 glycerol,
25ŒºM vitaminB12,2 5Œºgm L‚àí1 chloramphenicol, and 50Œºgm L‚àí1 kanamycin in microplates for 9 h. e) 3-HP production and yield of strains exhibiting
>twofoldchangesinspeciÔ¨ÅcÔ¨Çuorescenceduringshake-Ô¨Çaskfermentation.StrainswereculturedinmodiÔ¨ÅedM9mediumsupplementedwith15gL ‚àí1
glycerol, 25ŒºM vitamin B12,2 5Œºgm L‚àí1 chloramphenicol, and 50Œºgm L‚àí1 kanamycin for 48 h (n = 3). f) Comparison of 3-HP titers before and after
selection. Prior to selection,n = 9 colonies were randomly picked; after selection,n = 29 colonies exhibiting> twofold speciÔ¨Åc Ô¨Çuorescence increase
wereevaluated( p < 0.0001).g,h)Time-course proÔ¨Ålesof3-HPtiter,residualglycerol,DCM,andacetateinstrainsTDS6andTDHPTS6.Strainswere
cultured in modiÔ¨Åed M9 medium containing 15 g L‚àí1 glycerol, 25ŒºM vitamin B12,2 5Œºgm L‚àí1 chloramphenicol, and 50Œºgm L‚àí1 kanamycin for 48 h
(n = 3). i) Fed-batch fermentation proÔ¨Åle of strain TDHPT S6 (n = 2). j) Schematic representation of serial transfer experiments for evaluating strain
stabilityacrossmultiplepassages.k)Stabilityof3-HPtoleranceandproductioninstrainTDHPTS6overnineserialshake-Ô¨Çaskpassages.Toleranc ewas
assessedinthepresenceof720mM3-HP,while3-HPproductionwasevaluatedunderstandardconditionswithoutexogenous3-HP( n= 3).Dataare
presented as mean¬± SD from independent biological replicates. Statistical signiÔ¨Åcance was determined using a two-tailed Student‚Äôst-test, *p < 0.05,
**p<0.01,***p< 0.001.(a,c,j)werecreatedinBioRender.Zhang,Y.(2025) https://BioRender.com/p4jpcx5,andlicensedforpublication.
werepresumablycausedbysignalsaturation,therebydiminish-
ing the sensor‚Äôs ability to discriminate between intracellular 3-
HP levels during the later stages. Interestingly, we found that
thespeciÔ¨ÅcÔ¨Çuorescenceintensitiesmeasuredinvivoat9hwere
lower than those obtained from in vitro with externally supple-
mented 3-HP (Figure3j; FigureS9a, Supporting Information),
likely due to the fact that intracellular 3-HP levels had not yet
peakedatthisearlyfermentationstage.Despitethis,theseresults
conÔ¨ÅrmthatthebiosensorcaneÔ¨Äectivelydistinguishstrainswith
varying 3-HP production capacities, demonstrating its potential
asahigh-throughputplatformforidentifying‚Äúwin-win‚Äùindivid-
ualsfromthe3-HP-tolerantpopulationderivedfromdroplet2.
Adv. Sci.2025,12,e07740 e07740(9of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
2.5.2. High-Throughput Screening of Superior 3-HP-Producing
Individuals
Toidentifyhigh-performanceindividualswithelevated3-HPpro-
duction,theSENT6biosensorwasappliedinamulti-stepselec-
tionprocess,whichincludedplate-basedprescreening,deep-well
platescreening,andshake-Ô¨ÇaskveriÔ¨Åcation(Figure 4c).Initially,
cultures derived from droplet 2 were prepared as electrocom-
petent cells and transformed with plasmids p15A-tac-dhaBCE-
gdrAB-glpF-SENSOR and pBR322-trc-KpydcW. The transformed
cells were then plated on modiÔ¨Åed M9 agar containing 10 g L‚àí1
glycerol and 25ŒºM vitamin B12. After incubation, colonies with
visibleÔ¨Çuorescencewereobserved(Figure S9b,SupportingInfor-
mation),amountingto ‚âà3√ó105 colonies.Amongthese,colonies
displayingstronggreenÔ¨Çuorescenceweremanuallyselectedfor
further evaluation and transferred to LB medium to establish
seedculturein96-welldeepplates.Eachplatecontained95candi-
datestrainsandonecontrolstrain,HP0000(chassisTDcarrying
thesameplasmids).Intotal,11wellplates,encompassing 1045
colonies(HP0001‚ÄìHP1045)wereprocessed.Theselectedstrains
werecultivatedinmodiÔ¨ÅedM9mediumcontaining10gL ‚àí1 glyc-
eroland25 ŒºMvitaminB 12 indeep-wellplates.SpeciÔ¨ÅcÔ¨Çuores-
cence intensities were measured, and the relative Ô¨Çuorescence
changes (HPn/HP0000, n = 1‚Äì1045) were subsequently calcu-
lated.Fluorescenceintensitychangesrangedfrom0.42-to2.43-
fold.Notably,29strainsexhibitedÔ¨Çuorescenceintensitychanges
exceeding twofold (Figure4d). These strains were selected for
shake-Ô¨Çask fermentation to validate their 3-HP production ca-
pacities, with HP0000 as the control. To ensure suÔ¨Écient sub-
strate availability during fermentation, the initial glycerol con-
centrationwasincreasedto15gL ‚àí1.Thisadjustmentwasbased
on prior observations showing that 10 g L‚àí1 glycerol was nearly
depleted by strain TD S6 within 48 h (Figure1e), and that the
evolved strains might exhibit an enhanced capacity for glycerol
utilization under the same conditions. It was shown that 23 of
the 29 selected strains signiÔ¨Åcantly outperformed the control (p
< 0.05; Figure4e). Among these, strain HP0032 exhibited the
highest3-HPproductionof8.98gL ‚àí1,representingasigniÔ¨Åcant
increase of 74.03% compared to the 5.16 g L‚àí1 observed in the
control(p< 0.001).Moreover,HP0032exhibiteda3-HPyieldof
0.81molmol ‚àí1 glycerol,whichwasthehighestamongalltested
strains(Figure 4e).
When comparing postselection strains (HPn series, n = 1‚Äì
1045)topreselectionstrains(HPRAND nseries,n= 1‚Äì9),anin-
creasein3-HPproductionwasobservedfollowingtheapplication
of biosensor-assisted selection (Figure4f). Preselection strains
produced3-HPintherangeof2.73to5.70gL ‚àí1,withanaverage
of 4.71 g L‚àí1 and a median of 4.84 g L‚àí1. In contrast, postselec-
tionstrainsproduced3-HPrangingfrom4.24to8.98gL ‚àí1,witha
meanof6.65gL ‚àí1 andamedianof6.89gL ‚àí1.Statisticalanalysis
conÔ¨Årmed that 3-HP production was signiÔ¨Åcantly enhanced af-
terbiosensorscreening( p< 0.0001),highlightingtheeÔ¨Écacyof
biosensor-assistedselection.However,itisalsoworthnotingthat
afewselectedstrainsexhibitedlower3-HPtitersthanthecontrol
duringshake-Ô¨Çaskvalidation(Figure 4e).Thisoutcomemightbe
attributed to the inherent genetic diversity of the evolved pop-
ulation derived from droplet 2, where IVM introduced a broad
rangeofmutations.Giventhatthebiosensoroutputnotonlyde-
pendsonintracellular3-HPconcentrationsbutalsofactorssuch
assignaltransductioneÔ¨Éciencyandreporterexpression,certain
genome-level mutations may have indirectly enhanced Ô¨Çuores-
cencewithoutimprovingbiosyntheticcapacity.Forexample,mu-
tationsmayhavealteredtranscriptionalregulation,increasedex-
pressionresourceallocation,orimprovedsfGFPstability,thereby
elevating the signal independent of actual product formation.
Consequently,somestrainswereprioritizedduringprescreening
duetostrongÔ¨Çuorescencebutfailedtomaintainsuperiorperfor-
mance in subsequent veriÔ¨Åcation. This underscores the impor-
tanceoffollow-upveriÔ¨Åcationstepstoensuretherobustnessand
reliability of biosensor-assisted selection. Furthermore, our cur-
rentworkÔ¨Çowrepresentsabalancebetweenscreeningstringency
andpracticalconsiderationssuchasthroughput,labor,andtime.
SpeciÔ¨Åcally,althoughtheinitialplate-basedselectionenabledus
to visually pre-enrich Ô¨Çuorescent colonies from a large popula-
tion(‚âà3√ó105),thesubsequenthigh-throughputscreeningin96-
welldeepplateswaslimitedto1045isolatedclonesduetoprac-
ticalconstraints.Thisnumber,despitesubstantialforscreening,
still represents a small fraction of the initial library. As a result,
it is likely that some of the high-performing strains, potentially
surpassingHP0032,werenotcaptured.
2.6.EvaluationofBiosyntheticPerformanceandStability
To eliminate the potential metabolic burden imposed by
the biosensor element, plasmids p15A-tac-dhaBCE-gdrAB-glpF-
SENSOR and pBR322-trc-KpydcW were cured from the selected
strain HP0032 using CRISPR technology (FigureS10, Support-
ingInformation).Theresultingplasmid-freechassis,designated
TDHPT, was subsequently re-transformed with plasmids p15A-
tac-dhaBCE-gdrAB-glpFandpBR322-trc-KpydcW,resultinginthe
creation of the biosensor-free strain TDHPT S6. Fermentation
tests were then carried out in modiÔ¨Åed M9 medium supple-
mented with 15 g L‚àí1 glycerol, with strain TD S6 serving as the
control. As a result, strain TDHPT S6 achieved a 3-HP titer of
9.17 g L‚àí1 and a yield of 0.80 mol mol‚àí1 glycerol, signiÔ¨Åcantly
surpassingthecontrolstrain( p< 0.001),whichproducedatiter
of5.31gL ‚àí1 andayieldof0.63molmol ‚àí1 glycerol(Figure 4g,h).
Theseresultsrepresentimprovementsof72.69%and26.98%in
titerandyield,respectively,forTDHPTS6comparedtothecon-
trol. Meanwhile, the concentration of the byproduct acetate was
signiÔ¨Åcantly reduced in TDHPT S6 (p < 0.001), potentially con-
tributingtotheenhanced3-HPyield(Figure 4g,h).
To fully elucidate the potential of strain TDHPT S6, we per-
formedfed-batchfermentationina10-Lbioreactorfollowingthe
protocols established in our previous study.[22] The biomass of
T D H P TS 6s u r p a s s e d1 4gL‚àí1 DCM after 48 h fermentation
(Figure 4i), nearly doubling that of the control strain TD S6
(7.56 g L‚àí1 DCM; FigureS11, Supporting Information). The Ô¨Å-
nal titer of 3-HP in TDHPT S6 reached 86.30 g L‚àí1 with a yield
of 0.82 mol mol‚àí1 glycerol and a productivity of 1.79 g L‚àí1 h‚àí1
(Figure 4i). By contrast, the control strain TD S6, under identi-
cal fermentation conditions, produced only 51.60 g L‚àí1 of 3-HP
(FigureS11,SupportingInformation).
Besides, we accessed the genetic stability of TDHPT S6
through successive passaging experiments (Figure4j). After re-
peated passaging, strain TDHPT S6 maintained robust growth
in medium containing 720 mM 3-HP (Figure4k). Meanwhile,
Adv. Sci.2025,12,e07740 e07740(10of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
the 3-HP production capacity of TDHPT S6 under passaging
conditions in the absence of 3-HP was also evaluated. The re-
sults showed that the strain consistently produced‚âà8.5 g L‚àí1
of 3-HP without signiÔ¨Åcant decline in production (p > 0.05),
indicating stable production performance over successive gen-
erations (Figure4k). Notably, TDHPT S6 was derived from the
parental strain HP0032 after elimination of endogenous plas-
midsandreintroductionofnewlyengineeredplasmids.Despite
extensivegeneticmodiÔ¨Åcations,TDHPTS6retainedthesuperior
traits of the parental strain HP0032. These Ô¨Åndings underscore
the genetic stability and high-performance characteristics of the
evolvedchassisTDHPT.
2.7.TranscriptomeAnalysisRevealingtheMechanismfor
EnhancedToleranceandBiosynthesis
Toinvestigatethegeneticmechanismsunderlyingtheenhanced
tolerance and biosynthesis of 3-HP, transcriptome sequencing
was performed using RNA extracted from both the parental
strain TD S6 and the evolved strain TDHPT S6 during the log-
arithmic phase. Comparative transcriptomic proÔ¨Åling identiÔ¨Åed
246diÔ¨Äerentiallyexpressedgenes(DEGs)inTDHPTS6relative
toTDS6,applyingathresholdoffalsediscoveryrate(FDR) <0.05
and|log2 foldchange| >1(Figure S12aandTable S4,Supporting
Information). Among these, 28 genes were upregulated, while
218weredownregulated(Figure S12b,SupportingInformation).
2.7.1. The Mechanism for Enhanced 3-HP Tolerance
GeneOntology(GO)functionalannotationoftheDEGsrevealed
enrichment across multiple categories (FigureS13, Supporting
Information). Within the ‚ÄúBiological process‚Äù category, terms
such as ‚ÄúCellular process,‚Äù ‚ÄúMetabolic process,‚Äù and ‚ÄúResponse
to stimulus‚Äù were notably enriched. For the ‚ÄúMolecular func-
tion,‚Äù prominent terms included ‚Äúbinding,‚Äù ‚Äúcatalytic activity,‚Äù
and‚Äútransporteractivity.‚ÄùInthe‚ÄúCellularcomponent‚Äùcategory,
‚Äúcell,‚Äù ‚Äúcell part,‚Äù and ‚Äúmembrane‚Äù emerged as enriched terms.
Notably, the enrichment of terms such as ‚ÄúResponse to stimu-
lus,‚Äù‚ÄúTransporteractivity,‚Äù‚ÄúCellpart‚Äùand‚ÄúMembrane‚Äùappeared
to be linked to the molecular mechanisms conferring 3-HP tol-
erance. SpeciÔ¨Åcally, DEGs associated with ‚ÄúResponse to stimu-
lus‚Äù may enhance the strain‚Äôs ability to adapt to environmen-
tal changes under organic acid stress conditions by regulating
the expression of stress response pathways. The enrichment in
‚ÄúTransporteractivity‚Äùsuggeststhatmembranetransportsystems
couldplayakeyrolein3-HPtolerance,potentiallythroughtheac-
tiveeÔ¨Ñuxof3-HPorintracellularpHregulationtomitigatetoxi-
city.Additionally,DEGsenrichedin‚ÄúCellpart‚Äùand‚ÄúMembrane‚Äù
emphasizethecriticalroleofthecellmembraneintransportand
interactions with the external environment. Functional changes
inthecellmembrane,possiblybymodulatingthecompositionof
membrane proteins and lipids, could enhance tolerance. These
Ô¨Åndingsprovidevaluableinsightsintothemechanismsunderly-
ing3-HPtolerance.
To validate these Ô¨Åndings, we focused on speciÔ¨Åc genes im-
plicated in 3-HP tolerance, as identiÔ¨Åed through transcriptomic
analysis and corroborated by literature review. Eleven upregu-
lated genes (glsA, yqjG, hyaC, ygdI, dps, cysT, hyaE, ybaT, yqjE,
slp,and ynaI)andsevendownregulatedgenes( ompT,ompF,btsT,
msbA,metN,metI,a n dybjJ) were selected for further functional
analysis. Overexpression of the upregulated genes or knockout
of the downregulated genes was performed in the parental TD
strain,andspeciÔ¨Åcgrowthratesoftheresultingstrainswereeval-
uatedinmodiÔ¨ÅedM9mediumwithandwithout360mM3-HP.
Strains carrying the empty plasmid pTrc99a served as controls.
As shown inFigure5a, overexpression of theynaI gene yielded
a signiÔ¨Åcant 33.8% increase in speciÔ¨Åc growth rate compared
to the control under 360 mM 3-HP (p < 0.001). The YnaI pro-
tein,alow-conductancemechanosensitivechannel,hasbeenre-
portedtoplayavitalroleincellularresponsestoenvironmental
stress.[32] Suchchannelsmayregulatemembranetensionandfa-
cilitate the eÔ¨Ñux of small solutes and ions,[33] which could help
cells adapt to volume Ô¨Çuctuations induced by organic acids like
3-HP(Figure 5b).Thismechanismmaycontributetomitigating
cellularstressandenhancingacidtolerance.Inaddition,overex-
pressionoftheDNAstarvation/stationaryphaseprotectionpro-
tein Dps and the outer membrane lipoprotein Slp also signiÔ¨Å-
cantlyimprovedspeciÔ¨Åcgrowthratesunder3-HPexposure( p<
0.001).Dpsisknowntoprotectcellsfromoxidativedamageand
DNA fragmentation during environmental stress conditions.[34]
Under 3-HP exposure, Dps may help safeguard genomic DNA
from acid-induced damage, thereby promoting cell survival and
growth (Figure5b). Meanwhile, Slp enhances the structural in-
tegrity of the bacterial outer membrane, serving as a protective
barrier against external stressors.[35] The increased membrane
stabilityassociatedwithSlpmayhelpcounteractthemembrane-
disrupting eÔ¨Äects of 3-HP, thus augmenting tolerance to acidic
conditions (Figure 5b). Taken together, the mechanosensitive
function of YnaI, the protective role of Dps, and the structural
reinforcementprovidedbySlpmaycollectivelycontributetothe
enhanced3-HPtoleranceobservedinTDHPTS6.Nevertheless,
it is important to note that other diÔ¨Äerentially expressed genes
may also play contributory roles, and further systematic studies
willberequiredtofullyelucidatethegeneticbasisof3-HPtoler-
ance.
2.7.2. The Mechanism for Enhanced 3-HP Biosynthesis Performance
Inadditiontotheenhanced3-HPtolerance,strainTDHPTS6ex-
hibited a marked improvement in 3-HP biosynthesis eÔ¨Éciency.
To elucidate the mechanisms underlying this superior pheno-
type,weperformedananalysisoftheassociatedmetabolicpath-
ways, with a focus on the Kyoto Encyclopedia of Genes and
Genomes (KEGG) enrichment results (FigureS14a, Supporting
Information).TheKEGGanalysisidentiÔ¨Åedenrichmentofgenes
in several metabolic pathways, including ‚ÄúBiosynthesis of sec-
ondary metabolites,‚Äù ‚ÄúArginine biosynthesis,‚Äù and ‚ÄúRibosome.‚Äù
Among these, ‚ÄúBiosynthesis of secondary metabolites‚Äù category
stood out as it encompassed the largest enriched genes, indi-
cating its potential role in driving the observed phenotypic en-
hancement. Interestingly, nearly all genes within this category
were downregulated in TDHPT S6 compared to the parental
strain(Figure S14b,SupportingInformation).ThisÔ¨Åndingsug-
gestedthatthecellsmayoptimizecarbonallocationbydownreg-
ulating secondary metabolism, thereby redirecting carbon Ô¨Çux
awayfromsecondarymetabolitesynthesisandtowardthe3-HP
Adv. Sci.2025,12,e07740 e07740(11of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
Figure5. Investigationofregulatorymechanismsunderlyingenhanced3-HPtoleranceandbiosyntheticeÔ¨ÉciencyinevolvedstrainTDHPTS6.a)EÔ¨Äects
ofrelevantDEGmodiÔ¨ÅcationonstraingrowthratesinM9mediumwithandwithout360mM3-HPsupplementation.‚Äú +‚Äùdenotestheoverexpression
of signiÔ¨Åcantly upregulated DEGs, while ‚Äú‚àí‚Äù indicates the knockout of signiÔ¨Åcantly downregulated DEGs (n = 3). b) Proposed mechanisms by which
YnaI, Dps, and Slp contribute to improved 3-HP tolerance. c) Transcriptomic comparison between TDHPT S6 and its parental strain TD S6, each with
threebiologicalreplicates( n= 3),highlightingdiÔ¨Äerentialgeneexpressionwithinthe3-HPbiosyntheticpathway,theEMPpathway,andtheTCAcycle.
Upregulatedanddownregulatedgenesareshownasredandbluecircles,respectively;asterisks(*)denotesigniÔ¨ÅcantDEGs(FDR <0.05and|log 2 fold
change| > 1). d) qPCR veriÔ¨Åcation of representative DEGs involved in central metabolism, includinggapA, gltA, mdh, aceA,a n daceB (n = 3). Relative
gene expression was calculated using the 2‚ÄìŒîŒîCt method. A schematic overview of metabolic nodes related to glycerol utilization and central carbon
metabolismisshownforreference.Abbreviations:Gly3P,glycerol-3-phosphate;DHAP,dihydroxyacetonephosphate,GAP,glyceraldehyde-3-phos phate;
1,3-BPG,1,3-bisphosphoglycerate;3-PG,3-phosphoglycerate;2-PG,2-phosphoglycerate;PEP,phosphoenolpyruvate;PYR,pyruvate;AcCoA,acet yl-CoA;
CIT, citrate; ICIT, isocitrate; AKG,ùõº-ketoglutarate; SUC, succinate; SUC-CoA, succinyl-CoA; FUM, fumarate; MAL, malate; and OAA, oxaloacetate. Data
are presented as mean¬± SD from independent biological replicates. Statistical signiÔ¨Åcance was determined using a two-tailed Student‚Äôst-test, *p <
0.05,**p<0.01,***p<0.001.(b)werecreatedinBioRender.Zhang,Y.(2025) https://BioRender.com/i43zngl,andlicensedforpublication.
biosynthesispathway.Suchareallocationofresourcescoulden-
hanceboththeproductionandyieldof3-HPsynthesis,highlight-
ingapotentialadaptivemechanismforimprovingmetabolicef-
Ô¨Åciency.
In the metabolic network of TDHPT S6, glycerol metabolism
is funneled into three key pathways: 3-HP biosynthesis, glycol-
ysis, and the tricarboxylic acid (TCA) cycle (Figure5c,d). Given
that the transcription levels of genes directly involved in 3-HP
biosynthesisshowednosigniÔ¨Åcantchanges(Figure 5c),ouranal-
ysis focused on genes within the ‚ÄúBiosynthesis of secondary
metabolites‚Äù category, particularly those linked to glycolysis and
the TCA cycle. The results revealed that thegapA gene, which
encodes glyceraldehyde-3-phosphate dehydrogenase (GapA) in
theglycolyticpathway,wassigniÔ¨Åcantlydownregulatedinstrain
TDHPT S6 compared to the parental strain (Figure5c). The
downregulation ofgapA may help reduce carbon loss through
glycolysis,akeyadjustmentforoptimizingcarbonallocation. [36]
Previous studies have proved that moderate GapA activity is
crucial for maintaining a balance between cell growth and the
biosynthesis of target compounds.[37] In our study, although
gapA transcription was signiÔ¨Åcantly reduced in TDHPT S6, the
strainmaintainednormalgrowthandexhibitedenhanced3-HP
production eÔ¨Éciency. This observation suggests that the reduc-
tion ingapA transcription may not impair essential glycolytic
Ô¨Çux required for biomass generation but instead redirect more
metabolicresourcestoward3-HPbiosynthesis.
Within the TCA cycle, the genesgltA (encoding citrate syn-
thase) andmdh (encoding malate dehydrogenase), which gov-
ern the initiation and terminal steps of the cycle, respectively,
were also signiÔ¨Åcantly downregulated (Figure 5c,d). Concur-
rently, genes involved in the glyoxylate shunt,aceA (encoding
isocitrate lyase) and aceB (encoding malate synthase), exhib-
ited markedly reduced transcriptional levels (Figure5c,d). This
collective downregulation may contribute to minimizing car-
bon Ô¨Çux losses through the TCA cycle and potentially redi-
rect carbon more eÔ¨Éciently toward the 3-HP biosynthetic path-
way. To independently validate and reinforce the reliability of
the transcriptomic Ô¨Åndings, we performed quantitative PCR
(qPCR) analysis of these key genes associated with glycolysis
and TCA cycle. This additional step was included to help ad-
dress potential concerns related to platform-speciÔ¨Åc bias or se-
quencing artifacts. The results showed that transcription lev-
Adv. Sci.2025,12,e07740 e07740(12of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
els ofgapA, gltA, mdh, aceA,a n daceB were downregulated by
2.61-fold, 1.86-fold, 1.59-fold, 3.73-fold, and 2.11-fold, respec-
tively (Figure5d). These results were consistent with the tran-
scriptomicdata,furthersupportingourhypothesis.Insummary,
the downregulation of key genes in the ‚ÄúBiosynthesis of sec-
ondary metabolites‚Äù pathway, particularly those involved in gly-
colysis and the TCA cycle, in TDHPT S6 likely reduces car-
bon Ô¨Çux losses during glycerol metabolism. Such metabolic re-
programming is likely to contribute to minimize unnecessary
energy expenditure and improve carbon utilization eÔ¨Éciency,
thereby promoting the high-eÔ¨Éciency synthesis of 3-HP. While
these Ô¨Åndings indicate a potential metabolic shift toward en-
hanced 3-HP biosynthesis, the conclusions remain correlative.
In the absence of functional validation such as targeted gene
perturbationorintracellularmetaboliteproÔ¨Åling,thecausalrela-
tionshipbetweentranscriptionalchangesandtheimprovedpro-
duction phenotype cannot be deÔ¨Ånitively established. Neverthe-
less, the results oÔ¨Äer valuable hypotheses that warrant further
investigation.
3.Discussion
This study presents a reÔ¨Åned ALE strategy that overcomes the
classic trade-oÔ¨Ä between stress tolerance and biosynthetic eÔ¨É-
ciency in microbial production of toxic chemicals. We achieved
thisbyintroducingthreekeymodiÔ¨ÅcationstoconventionalALE:
(i) using a pre-mutagenized library as the starting population
instead of a wild-type strain, (ii) performing automated high-
throughputevolutioninphysicallyisolatedmicrodroplets(MMC
system), and (iii) integrating a metabolite-responsive biosen-
sor to couple Ô¨Çuorescence with biosynthetic performance. Tra-
ditional ALE typically requires several months of serial pas-
saging and relies on the slow accumulation of rare sponta-
neous mutations to yield tolerant mutants.[12,15] In contrast, our
strategy preloads genetic diversity through IVM, enabling se-
lection to immediately act on a broader mutational landscape.
By combining this diversity with automated parallel cultiva-
tion, we dramatically shortened the evolution timeline to un-
der 2 weeks while still obtaining mutants with superior 3-
HP tolerance and production capacity. Importantly, the built-in
biosensor accelerated identiÔ¨Åcation of ‚Äúwin-win‚Äù variants that
maintained high 3-HP biosynthesis alongside enhanced toler-
ance. Overall, our integrated approach markedly improves on
conventional ALE by rapidly co-optimizing two traits (toler-
ance and biosynthetic eÔ¨Éciency) rather than each trait in isola-
tion.
Mechanistically, pre-evolution mutagenesis via IVM primed
the cell population for accelerated adaptation by ensuring ad-
vantageous alleles were present from the outset. Once evolu-
tion commenced in the MMC system under escalating 3-HP
stress, cells carrying beneÔ¨Åcial mutations quickly outcompeted
others. Meanwhile, the 3-HP biosensor enabled the identiÔ¨Åca-
tionofmutantswithsuperiorbiosyntheticcapacitybylinkingin-
tracellular 3-HP levels to Ô¨Çuorescence output, thereby allowing
strong-Ô¨Çuorescing candidates to be preferentially retained dur-
ing screening. This dual selection addresses a common pitfall
intoleranceevolution,wheremutantsoftensurvivebydiverting
resources away from production.[17] Instead, our ‚Äúwin-win‚Äù se-
lection pressure favored strains striking a balance between sur-
vivalandbiosynthesis.Theoutcomewasapanelofevolved E.coli
strainsthatnotonlytolerateextremelyhigh3-HPconcentrations
(up to 720 mM) but also sustain robust 3-HP synthesis. From
a mechanistic perspective, these top-performing mutants likely
harborcombinationsofmutationsthatmitigate3-HPtoxicity(for
instance, increasing eÔ¨Ñux of 3-HP) while preserving metabolic
Ô¨Çuxthroughthe3-HPpathway.
Further comparative transcriptomic analysis of the parental
and evolved strains provided further insight into how the trade-
oÔ¨Ä between tolerance and production was resolved. Rather than
upregulating a narrow set of stress-speciÔ¨Åc genes, the tolerant
high-producing strain exhibited broad structural and metabolic
adaptations. Several genes involved in membrane structure,
transport,andstressresponsewerediÔ¨Äerentiallyexpressed,sug-
gesting that enhanced 3-HP tolerance was achieved via global
cell envelope remodeling and improved eÔ¨Ñux capacity, rather
than a single protective mechanism. Notably, key genes in cen-
tralcarbonmetabolismweredownregulatedintheevolvedstrain,
including gapA, gltA,a n dmdh. This shift indicates a realloca-
tion of carbon Ô¨Çux: by tempering glycolysis and the TCA cy-
cle, the cells diverted more resources toward the 3-HP biosyn-
thetic pathway. Similar Ô¨Çux redistribution has been observed in
other organic acid production contexts, where reducing activ-
ity of central metabolic pathways can channel more precursors
to the target product.[36] Consistent with this, we also observed
downregulation of genes for secondary metabolite biosynthesis
in the evolved strain, suggesting a deliberate simpliÔ¨Åcation of
metabolism to minimize energy dissipation. The alignment be-
tween these transcriptomic changes and the improved pheno-
type underscores the eÔ¨Äectiveness of our ALE strategy. It ap-
pears that evolution in our system selected for a more econo-
mized metabolic state that fortiÔ¨Åes cellular defenses while ef-
Ô¨Åciently funneling carbon to 3-HP production. These Ô¨Åndings
not only illuminate the biological basis of the ‚Äúwin-win‚Äù phe-
notype but can also guide rational engineering in other sys-
tems facing similar toxicity challenges. The Ô¨Ånal evolved strain
(TDHPT S6) demonstrated exceptional performance in both
Ô¨Çask and scaled fermentation trials, highlighting the practical
beneÔ¨Åts of our approach. In shake-Ô¨Çask tests, TDHPT S6 grew
vigorously in the presence of 720 mM 3-HP, a concentration
that completely inhibited the parental strain. This strain also
substantially outperformed the unevolved strain in 3-HP pro-
duction. In 10-L bioreactor fed-batch fermentation, TDHPT S6
achieved a 3-HP titer of 86.3 g L‚àí1,r e p r e s e n t i n ga n‚âà67% in-
crease over the parental strain under identical conditions, and
nearlydoubledtheÔ¨Ånalbiomass.Thisdramaticimprovementin
titer and growth demonstrates the strain‚Äôs superior robustness
and conÔ¨Årms its industrial potential for 3-HP biomanufactur-
ing.
Despite these encouraging outcomes, several limitations of
ourcurrentstrategyshouldbeacknowledged.First,thegenome-
wide mutagenesis (IVM) introduces a vast number of random
mutations,someofwhichcouldinadvertentlyinÔ¨Çatethebiosen-
sorsignal(e.g.,byalteringtranscriptionalregulationorimprov-
ing sfGFP stability) without truly enhancing production. Such
false positives might cause highly Ô¨Çuorescent clones to be se-
lected even if their 3-HP biosynthesis is not signiÔ¨Åcantly im-
proved. Although we calibrated the biosensor and conÔ¨Årmed
product titers in shake-Ô¨Çask tests, there remains a risk that cer-
Adv. Sci.2025,12,e07740 e07740(13of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
tainbeneÔ¨Åcial-lookingmutationsmayprimarilyaÔ¨Äectthesensor
readoutratherthanthemetabolicoutput.Second,ourscreening
throughput of‚âà103 clones in deep-well plates is modest com-
pared to modern ultra-high-throughput techniques capable of
processing 106 to 108 variants. It is likely that we sampled only
a small fraction of the total mutant library, and some ultra-rare,
top-performing variants were missed due to practical through-
put limits and stringent selection thresholds. This trade-oÔ¨Ä be-
tween screening feasibility and coverage is an inherent chal-
lenge in manual ALE workÔ¨Çows. Third, the context-speciÔ¨Åc na-
ture of evolved mutations means that certain tolerance mecha-
nismsmightnotdirectlytranslatetootherproductionpathways
or host organisms. Furthermore, the use of multicopy plasmids
forthebiosensorandpathwaygenes,whileconvenient,canintro-
duce variability in gene expression and metabolic burden, com-
plicatingthegenotype-phenotyperelationship.Theseconsidera-
tionsunderscoretheimportanceofthoroughphenotypicvalida-
tionofevolvedstrainsandpointtoopportunitiesforreÔ¨Åningthe
platform.
Lookingahead,thereareseveralavenuestoenhanceandgen-
eralizethereÔ¨ÅnedALEstrategy.Tocaptureabroadermutational
landscape and reduce selection bias, future studies could incor-
porate ultra-high-throughput single-cell screening technologies.
For example, microÔ¨Çuidic droplet sorting or Ô¨Çuorescence-
activated cell sorting (FACS) could enable interrogation of mil-
lions of variant cells, greatly increasing the chance of isolating
rare superior mutants. In parallel, full automation of the evolu-
tion and screening workÔ¨Çow with robotic liquid handling and
multiplexedcultivationsystemswouldfacilitatelarge-scalerepli-
cateALEexperimentsunderpreciselycontrolledconditions.This
would not only improve the statistical power of detecting true
adaptive changes but also help distinguish beneÔ¨Åcial mutations
from neutral drift. The framework itself is inherently modular
andcanbereadilyextendedtoothertargetmolecules.Byreplac-
ing the biosensor with one based on a diÔ¨Äerent transcription
factororriboswitch,thesamestrategycouldbeappliedtoevolve
toleranceandproductivityforawiderangeoftoxicbioproducts,
including alcohols, organic acids, and aromatic compounds.
Moreover, coupling our ALE approach with comprehensive sys-
temsbiologyanalyses(e.g.,whole-genomesequencingofevolved
lines, transcriptomics, proteomics, and metabolic modeling)
will deepen understanding of adaptive mechanisms and reveal
speciÔ¨Åc genetic targets for further rational engineering. Future
implementationsmayalsoincorporatedirectedmutagenesisap-
proaches,includingCRISPR-enabledgenomediversiÔ¨Åcationand
pathway-focusedstrategies,toenrichmutationswithinpathways
known to aÔ¨Äect tolerance or productivity and minimize the ac-
cumulationofharmfulvariants.Finally,systematicallymapping
the quantitative relationship between stress tolerance and pro-
ductionindiversehosts,andscalingupthisstrategytoindustrial
bioreactors,willbeimportantfortestingitsrobustnessandbroad
applicability. In summary, our reÔ¨Åned ALE strategy provides an
eÔ¨Écientandgeneralizableframeworkforengineeringmicrobial
cellfactoriesthatthriveunderhighproducttoxicitywhilemain-
taining high biosynthetic performance. It not only accelerates
thedevelopmentofrobustproductionstrainsfor3-HP,butalso
lays a foundation for tackling tolerance-productivity trade-oÔ¨Äs
in the microbial production of many other valuable yet toxic
chemicals.
4.ExperimentalSection
Reagents: The Phanta Flash Master Mix (Dye Plus) for DNA ampliÔ¨Å-
cation and the AceQ Universal SYBR qPCR Master Mix for qPCR analysis
were purchased from Vazyme Biotech (Nanjing, China). The HiScript II
Q RT SuperMix for qPCR (+gDNA wiper) was also bought from Vazyme
Biotech(Nanjing,China).TheMultiFSeamlessAssemblyMixforGibson
assembly was supplied by ABclonal Technology (Wuhan, China). Quick-
CutrestrictionendonucleaseswereobtainedfromTakaraBiomedicalTech-
nology (Beijing, China). Antibiotics, including kanamycin, chlorampheni-
col, ampicillin, and spectinomycin, were sourced from Solarbio Science
& Technology (Beijing, China). Oligonucleotide synthesis and sequenc-
ing services were provided by Azenta Life Science (Suzhou, China). 3-HP
(‚âà30%inwater,3.6molL ‚àí1)wasacquiredfromTCIDevelopmentCo.,Ltd.
(Shanghai, China). The non-ionic T-F composite defoamer for fermenta-
tion was purchased from Sangon Biotech (Shanghai, China). Unless oth-
erwise speciÔ¨Åed, additional chemicals were purchased from Sinopharm
ChemicalReagentCo.Ltd.(Shanghai,China).
Strains, Plasmids, Primers and Growth Conditions: The strains, plas-
mids, and primers employed in this study are presented in TablesS1‚ÄìS3,
Supporting Information, respectively.E. coliDH5ùõº served as the cloning
host,while E.coli W3110wasusedasthestartingchassisfor3-HPbiosyn-
thesis.PlasmidspCasandpTargetFwereutilizedforgenomeediting,while
theplasmidMP6wasmodiÔ¨Åed tofacilitateinvivomutagenesisin E. coli.
The plasmid pUC57Kan-SENSOR, containing 3-HP biosensor elements,
was synthesized by Azenta. LB medium, composed of 10 g L‚àí1 NaCl,
10gL ‚àí1 tryptone,and5gL ‚àí1 yeastextract,wasusedforgeneticmanipula-
tionsandseedculturepreparation.Whennecessary,themediumwassup-
plementedwithchloramphenicol(25 ŒºgmL‚àí1),kanamycin(50 ŒºgmL‚àí1),
spectinomycin(50 ŒºgmL‚àí1),orampicillin(100 ŒºgmL‚àí1).
Plasmid and Strain Construction : The primers used for plas-
mid construction are listed in Table S3, Supporting Information.
To construct plasmids for the constitutive expression of dhaBCE-
gdrAB-glpF under the tac promoter (tac promoter sequence: 5 ‚Ä≤-
TTGACAATTAATCATCGGCTCGTATAATG-3‚Ä≤), the dhaBCE-gdrAB-glpF
fragment was ampliÔ¨Åed using the primers DGF F/R with the plasmid
pCDF-dhaBCE-gdrAB-glpF as the template. Simultaneously, the plasmid
p15A-tac was linearized via reverse PCR using primers backbone1 F/R.
The linearized vector and ampliÔ¨ÅeddhaBCE-gdrAB-glpF fragment were
ligated to construct p15A-tac-dhaBCE-gdrAB-glpF. Subsequently, reverse
PCRwasperformedonp15A-tac- dhaBCE-gdrAB-glpFusingbackbone2F/R
to remove the p15A origin of replication. The origins ColA, ColDF13, and
pBR322wereampliÔ¨ÅedfrompCOLADuet-1,pCDFDuet-1,andpETDuet-1,
respectively, using primers Ori1-ColA F/R, Ori1-ColDF13 F/R, and Ori1-
pBR322 F/R. These origins were inserted into the linearized backbone
to create the plasmids pCOLA-tac-dhaBCE-gdrAB-glpF,p C O L D F 1 3 - t a c -
dhaBCE-gdrAB-glpF, and pBR322-tac-dhaBCE-gdrAB-glpF. For the expres-
sion of theKpydcW gene, the plasmid pRSF-KpydcW served as the tem-
plate, from which theKpydcW gene was ampliÔ¨Åed using primersKpydcW
F/R. The plasmid pBR322-trc was linearized with primers backbone3 F/R
(trcpromotersequence:5 ‚Ä≤-TTGACAATTAATCATCCGGCTCGTATAATG-3‚Ä≤).
Ligationofthe KpydcWgenewiththelinearizedvectorproducedpBR322-
trc-KpydcW. Reverse PCR with primers backbone4 F/R removed the
pBR322 origin of replication. The origins p15A, ColDF13, and RSF were
ampliÔ¨Åed from pACYCDuet-1, pCDFDuet-1, and pRSFDuet-1, respec-
tively, using primers Ori2-p15A F/R, Ori2-ColDF13 F/R, and Ori2-pRSF
F/R. These origins were inserted into the linearized backbone, yielding
p15A-trc-KpydcW,pCOLDF13-trc-KpydcW,andpRSF-trc- KpydcW.
To construct the plasmid pMP6ts, the parental plasmid MP6 was
digested with NcoIa n d XbaI, yielding a fragment containing the
araC-pBAD-dhaQ926-dam-seqA-emrR-ugi-Pmcda1cassette.Tointroducea
temperature-sensitive origin, the plasmid pCas was used as a template
for the ampliÔ¨Åcation of the KanR and the temperature-sensitive origin
pSC101(ts) using primers KanR-TS F/R. The ampliÔ¨Åed KanR-pSC101(ts)
fragment was then ligated with thearaC-pBAD-dhaQ926-dam-seqA-emrR-
ugi-Pmcda1tocreatetheplasmidpMP6ts.
The plasmid pSEN T0 was constructed using the synthesized plasmid
pUC57Kan-SENOR as a template to amplify the PhpTD-PJ23109-hpTDR
Adv. Sci.2025,12,e07740 e07740(14of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
fragment with primers SENSOR ELE F/R. ThesfGFP-rrnB T fragment
was ampliÔ¨Åed from the pTrc99a-sfGFP plasmid using primers sfGFP
F/R. Additionally, the p15A origin of replication and the CmR were
ampliÔ¨Åed from the plasmid pACYCDuet-1 using primers p15A F and
CmR R. These three ampliÔ¨Åed fragments were ligated to generate the
plasmid pSEN T0. To construct pSEN POSI, the plasmid pSEN T0
served as a template for reverse PCR using primers backbone5 F/R,
facilitating the removal of thehpTDR gene. The resulting PCR product
was subsequently self-ligated, producing the plasmid pSEN POSI. In
a similar manner, pSEN NEGA was generated by performing reverse
PCR on pSEN T0 using primers backbone6 F/R. To construct biosen-
sor plasmids with diverse ribosome binding site (RBS) combinations,
three RBS sequences were selected from the Standard Biological Parts
Database (https://parts.igem.org/Ribosome_Binding_Sites/Prokaryotic/
Constitutive/Community_Collection). BBa_B0031, BBa_B0032, and
BBa_B0030 were chosen, exhibiting relative strengths of 0.07, 0.3, and
0.6a.u.,respectively.UsingtheplasmidpSENT0asthetemplate,reverse
PCRwasperformedwithprimersRBS1- hpTDRF/R,RBS2-hpTDRF/R,and
RBS3-hpTDR F/R to replace the original RBS of thehpTDR gene. The re-
sultingfragmentswereself-assembledtogenerateplasmidspSEN-RBS1,
pSEN-RBS2, and pSEN-RBS3. These plasmids were subsequently used
as templates to modify the RBS of thesfGFP gene. SpeciÔ¨Åcally, primers
RBS1-sfGFP F/R, RBS2-sfGFP F/R, and RBS3-sfGFP F / Rw e r eu s e dt o
create new RBS variants forsfGFP. In this manner, 9 new plasmids with
distinct RBS combinations were generated, designated as pSEN T1 ‚Äì
pSENT9.
Fortheconstructionofplasmidp15A-tac- dhaBCE-gdrAB-glpF-SENSOR,
thefragmentcontainingP J23109-B0032-hpTDRandPhpTD-B0030-sfGFPwas
ampliÔ¨Åed from plasmid pSEN T6 using primers SENSOR F/R. The plas-
midp15A-tac-dhaBCE-gdrAB-glpFwaslinearizedusingprimersbackbone7
F/R. The ampliÔ¨Åed fragment was then ligated into the linearized plasmid
p15A-tac-dhaBCE-gdrAB-glpF,yieldingtheÔ¨Ånalplasmidp15A-tac- dhaBCE-
gdrAB-glpF-SENSOR.
UsingplasmidpETDuet-1asthetemplate,theAmp R wasampliÔ¨Åedwith
primers AmpR F/R. A fragment containing the temperature-sensitive ori-
ginofreplicationpSC101(ts),P lacIq-lacI,andsgRNA-pBR322wasampliÔ¨Åed
from plasmid pCas using primers pSC101(ts) F and sgRNA R. Addition-
ally, thecas9 expression cassette was ampliÔ¨Åed from pCas with primers
cas9 F/R. The three ampliÔ¨Åed fragments were assembled to generate the
plasmidpELIM-pBR322.ToconstructplasmidpELIM-p15A,usingpELIM-
pBR322 as the template, reverse PCR with primers sgRNA-p15A F/R was
performedtoreplacetheoriginalsgRNA-pBR322sequence.Theresulting
DNAfragmentwasself-ligatedtoyieldpELIM-p15A.
To construct plasmids for the overexpression of genesglsA, yqjG,
hyaC, ygdI, dps, cysT, hyaE, ybaT, yqjE, slp,a n dynaI, plasmid pTrc99a
was linearized with primers pTrc99a F/R to generate the plasmid back-
bone. GenesglsA, yqjG, hyaC, ygdI, dps, cysT, hyaE, ybaT, yqjE, slp,a n d
ynaI were ampliÔ¨Åed from the genomic DNA ofE. coliW3110 usingglsA
F/R, yqjG F/R, hyaC F/R, ygdI F/R, dps F/R, cysT F/R, hyaE F/R, ybaT
F/R, yqjE F/R, slp F/R, andynaI F/R, respectively. These ampliÔ¨Åed genes
were inserted into the linearized pTrc99a backbone to form pTrc99a-
glsA,pTrc99a-yqjG,pTrc99a-hyaC,pTrc99a-ygdI,pTrc99a-dps,pTrc99a-cysT,
pTrc99a-hyaE, pTrc99a-ybaT, pTrc99a-yqjE, pTrc99a-slp, and pTrc99a-ynaI,
respectively.
For genome-scale gene editing, the CRISPR/Cas9 system, consisting
of pCas and pTargetF, was employed. The primers and plasmids used for
geneeditingweredetailedinTable S3,SupportingInformation.
In Vivo Mutagenesis and Adaptive Laboratory Evolution: To generate
mutagenizedlibrariesof E.coli,theIVMplasmidpMP6tswasutilized.The
plasmidpMP6tswasÔ¨ÅrstintroducedintothechassisstrainTD,resulting
in the strain TD MP6ts. This strain was subsequently inoculated into LB
medium supplemented with varying concentrations of L-arabinose (0.01,
0.1, 1, and 10 mM). The cultures were incubated at 30¬∞C for 12 h. Fol-
lowing this initial incubation, the cultures were pooled and incubated for
an additional 12 h at 42¬∞C to facilitate the curing of plasmid pMP6ts. Af-
terincubation,thecellswereharvestedbycentrifugation,resuspendedin
15% (v/v) glycerol, and stored at‚àí80 ¬∞C as the TD-MUT mutant library
forfutureexperiments.
To improve the tolerance ofE. colito 3-HP, ALE was performed using
the TD-MUT library as the starting population. The ALE experiment was
conducted following the guidelines of the MMC system. The preserved
TD-MUT library wasdiluted in modiÔ¨Åed M9 medium containing10 g L‚àí1
glyceroltoaninitialOD 600 of‚âà0.2,preparingitforthesubsequentevolu-
tion process in the MMC system. The MMC system utilized bottles con-
taining modiÔ¨Åed M9 medium with varying concentrations of 3-HP: bottle
No.4contained0mM,whilebottleNo.6contained720mM(neutralized
with10MNaOH).Additionally,themediumsupplementedwith3-HPwas
sterilizedthrougha0.22 ŒºmÔ¨Ålterpriortouse.TheALEprocessbeganwith
an18-hactivationphaseina3-HP-freemedium.Afterthisphase,eightin-
creasinggradientsof3-HPwereestablished,eachincrementedby90mM.
For each gradient, three successive passages were carried out at 12-h in-
tervals.Atotalof50microdropletcultureunitsweregeneratedtofacilitate
synchronized evolution, with adaptive evolution conducted over a 12-day
period. At the termination of ALE, the three droplets exhibiting the high-
estODMMC valueswereindividuallyselectedandextracted.Eachofthese
dropletswassubsequentlycultivatedin5mLofmodiÔ¨ÅedM9mediumsup-
plementedwith10gL ‚àí1 glyceroltofacilitatefurtheranalysis.
Bioinformatics Analysis: The protein family of HPTDR was predicted
using the Blast function available on the UniProt online tool (https://
www.uniprot.org/blast).TofurtheridentifythedomainsofHPTDR,theIn-
terPro online tool (https://www.ebi.ac.uk/interpro/) was utilized. The 3D
structureoftheHPTDRproteinmonomerwaspredictedusingAlphaFold
Server(https://alphafoldserver.com/).The3-HPmoleculewasdrawnand
energy-minimized using ChemDraw and Chem3D. Subsequently, molec-
ular docking simulations between the 3-HP molecule and the substrate
recognition domain of the HPTDR model were performed using Discov-
eryStudio.Finally,thedockingsimulationresultswerevisualizedwithPy-
MOL.
Characterization of Biosensors: Plasmids harboring biosensor ele-
ments were introduced into the chassisE. coliW3110, generating strains
equipped with biosensors for characterization. The resulting strainswere
cultivatedin96-deepwellplates,andafter9hofincubation,sampleswere
collected for analysis. Green Ô¨Çuorescence values and OD6nn values were
measured using black and clear microtiter plates, respectively. Fluores-
cencemeasurementswereconductedwithexcitationandemissionwave-
lengths set to 485 and 530 nm, respectively.[38] The speciÔ¨Åc Ô¨Çuorescence
intensitywasemployedtoevaluatetheoutputstrengthofthebiosensor‚Äôs
Ô¨Çuorescencesignal,whilethedynamicrangeservedasanindicatorofthe
biosensor‚Äôsmeasurementcapability.
SpeciÔ¨ÅcÔ¨Çuorescenceintensity (SFI) = Fluorescencevalue‚àïOD600 (1)
Dynamicrange = SFI5g ‚àïL3 ‚àíHP‚àïSFIwithout 3‚àíHP (2)
Biosensor-Assisted Selection of Superior 3-HP Producers: The parental
chassisTDandthepopulationderivedfromdroplet2weremadeintoelec-
trocompetent cells. The plasmids p15A-tac-dhaBCE-gdrAB-glpF-SENSOR
and pBR322-trc-KpydcW were co-transformed into the prepared compe-
tent cells via electroporation. The electroporation was performed using
a cuvette with a 1 mm gap under the following conditions: 1800 V, 200
Œ©,a n d2 5ŒºF. Cells were then incubated at 37¬∞C for 1 h before plating
on modiÔ¨Åed M9 agar supplemented with 25Œºgm L‚àí1 chloramphenicol,
50 Œºgm L‚àí1 kanamycin, 10 g L‚àí1 glycerol, and 25ŒºM vitamin B12.T h e
plates were incubated at 37¬∞C for 18 h. Single colonies exhibiting strong
greenÔ¨Çuorescencewereselectedandinoculatedintoa96-deepwellplate
containing LB liquid medium supplemented with 25Œºgm L‚àí1 chloram-
phenicol and 50Œºgm L‚àí1 kanamycin. Each plate consisted of 95 strains
derived from droplet 2 and a single TD-derived strain as a control. This
procedurewasrepeatedtogenerateatotalof11deepwellplates.Follow-
inga12-hincubationperiodat37 ¬∞C,seedcultureswereobtained.
Subsequently,1%(v/v)oftheseedcultureswereinoculatedintoanew
96-deep well plate containing modiÔ¨Åed M9 medium supplemented with
10 g L‚àí1 glycerol, 25ŒºM vitamin B12,2 5Œºgm L‚àí1 chloramphenicol, and
50 Œºgm L‚àí1 kanamycin. Fermentation was conducted for 9 h. The green
Ô¨Çuorescenceintensityandbiomassofeachstrainweresubsequentlymea-
sured. The ratio of Ô¨Çuorescence intensity to biomass was calculated and
Adv. Sci.2025,12,e07740 e07740(15of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
normalized to the control strain. Strains exhibiting Ô¨Çuorescence intensity
ratiosexceedingatwofoldchangerelativetothecontrolwereidentiÔ¨Åedfor
furtheranalysis.Theselectedhigh-performingcandidatesweresubjected
tofurtherfermentationinmodiÔ¨ÅedM9mediumcontaining15gL ‚àí1 glyc-
erol, 25ŒºM vitamin B12,2 5Œºgm L‚àí1 chloramphenicol, and 50Œºgm L‚àí1
kanamycin.Fermentationproceededfor48h,afterwhichthe3-HPproduc-
tion were quantiÔ¨Åed using HPLC. The concentrations of 3-HP and other
metabolitesweremeasuredbyHPLCasdescribedearlier. [21]
Elimination of Plasmids in Strain HP0032: The tool plasmid pELIMI-
p15A was transformed into strain HP0032, and the resulting strain was
inducedwith0.5mMIPTGat30 ¬∞Cand220rpmfor12htocuretheplas-
mid p15A-tac-dhaBCE-gdrAB-glpF-SENSOR. The curing of pELIMI-p15A
was achieved by incubation at 42¬∞C for 8 h, exploiting the temperature-
sensitiveinstabilityofthereplicon.Followingasimilarprotocol,theplas-
mid pRB322-trc-KpydcW was subsequently cured. These successive plas-
mideliminationstepsultimatelyresultedinthegenerationoftheplasmid-
freechassisstrain,designatedasTDHPT.
Transcriptome Analysis and qPCR VeriÔ¨Åcations: The initial parental
strain, TD S6, and the evolved strain, TDHPT S6, were plated on LB agar.
Single colonies were selected and inoculated into modiÔ¨Åed M9 medium
supplemented with 10 g L‚àí1 glycerol. Cultures were incubated at 37¬∞C
and 220 rpm until reaching the logarithmic growth phase (OD600 = 1.0
¬± 0.05). Cells were harvested, washed twice with potassium phosphate
buÔ¨Äer(100mM,pH7.0),andÔ¨Çash-frozeninliquidnitrogen.
The samples were packaged in a foam-insulated container with dry
ice and dispatched to Gene Denovo Biotechnology Co., Ltd (Guangzhou,
China).forRNAextractionandsequencinganalysis.Thetranscriptomese-
quencingwasperformedonanIlluminaHiseqTM4000sequencerbywith
a reference genome ofE. coliW3110 (NC_0 07779.1). Subsequent bioin-
formaticanalysiswasperformed ontheweb-basedtoolbox‚ÄúOmicsmart‚Äù
(http://www.omicsmart.com).DiÔ¨Äerentiallyexpressedgenes(DEGs)were
identiÔ¨Åedusingafalsediscoveryrate(FDR) <0.05and|log 2 foldchange|
> 1betweenTDS6andTDHPTS6.
After sequencing, the RNA samples were processed for subsequent
qPCRvalidation.FollowingreversetranscriptionwithHiScriptIIQRTSu-
perMix for qPCR (+gDNA wiper), selected cDNA targets were ampliÔ¨Åed
usingAceQUniversalSYBRqPCRMasterMixandthedesignatedprimers
(TableS3,SupportingInformation).Thereactionswerecarriedoutonthe
StepOne Plus system (Thermo Fisher ScientiÔ¨Åc) with SYBR Green detec-
tion, employingrecA gene as the internal reference control. Data analysis
wasperformedaccordingtothe2 ‚àíŒîŒîCT method.[39]
FlaskandBioreactorFermentationfor3-HPProduction : For shake-Ô¨Çask
scale production of 3-HP, single colonies of engineered strains were
picked up and cultured in LB medium at 37¬∞C and 220 rpm for 12 h.
The resulting cultivation was inoculated at 1% (v/v) ratio into a 250 mL-
Ô¨Çask containing 50 mL modiÔ¨Åed M9 medium. The medium composition
included 1 g L‚àí1 yeast extract, 0.8 g L‚àí1 MgSO4¬∑7H2O, 2 g L‚àí1 NH4Cl,
2gL ‚àí1 NaCl, potassium phosphate buÔ¨Äer (100 mM, pH 7.0), 5ŒºMv i t a -
min B12, and variable concentrations of glycerol. The shake-Ô¨Çask fermen-
tationswereconductedat37 ¬∞Cand220rpm.
For fed-batch fermentation, the medium contained 5 g L‚àí1 yeast
extract, 0.8 g L‚àí1 MgSO4¬∑7H2O, 2 g L‚àí1 NH4Cl, 2 g L‚àí1 NaCl, a
potassium phosphate buÔ¨Äer (100 mM, pH 7.0), 50ŒºM vitamin B12,
6gL ‚àí1 glucose, 40 g L‚àí1 glycerol, 5 mL L‚àí1 trace metal solution,
and 0.1% (v/v) antifoaming agent. Trace metal solution: 10 g L ‚àí1
FeSO4¬∑7H2O,2.2gL ‚àí1 ZnSO4¬∑7H2O,2gL ‚àí1 CaCl2,1gL ‚àí1 CuSO4¬∑5H2O,
0.5 g L‚àí1 MnSO4¬∑4H2O, 0.1 g L‚àí1 (NH4)6Mo7O24¬∑4H2O, 0.02 g L‚àí1
Na2B4O7¬∑10H2O, and0.5 M HCl.[22] The fermentation wasperformed in
a 10 L bioreactor with a working volume of 4 L. Freshly cultivated seed
culture was inoculated at 10% (v/v) into the fermentation medium. Ini-
tial fermentation parameters were set as follows: temperature at 37¬∞C,
stirringrateat500rpm,andanaerationrateof1vvm.ThepHwasmain-
tainedat ‚âà7.0byaddingaqueousammonia(25‚Äì28%).Duringthefermen-
tationprocess,intermittentmanualfeedingofaglycerolsolution(contain-
ing800gL ‚àí1 glyceroland5gL ‚àí1 yeastextract)wasemployedtosustain
theglycerolconcentrationat ‚âà20gL ‚àí1.Thestirringspeedwasautomati-
callyadjustedwithinarangeof500to1000rpmtomaintainthedissolved
oxygen (DO) level above 10%. If DO levels dropped below 10% despite
reaching the maximum stirring speed, the aeration rate was manually in-
creased to 2 vvm. When excessive foaming occurred, antifoaming agent
wasmanuallyaddedasneeded.Theentirefermentationprocessspanned
48h.
Statistical Analysis: Data are presented as the mean¬± standard de-
viation (SD) from independent biological replicates (n = 3 unless other-
wisestated).Nodatatransformationoroutlierexclusionwasapplied.Sta-
tistical signiÔ¨Åcance was evaluated using two-tailed Student‚Äôst-tests (for
two-groupcomparisons)orone-wayANOVA(formultiple-groupcompar-
isons)inGraphPadPrism9(GraphPadPrism,SanDiego,CA,USA),with
p< 0.05consideredstatisticallysigniÔ¨Åcant.
SupportingInformation
SupportingInformationisavailablefromtheWileyOnlineLibraryorfrom
theauthor.
Acknowledgements
This study was supported by the National Natural Science Foundation
of China (No. 32272284) and the Innovation & Entrepreneurship Team
ProjectofGuangzhou,China(No.2024D03J0012).
ConÔ¨ÇictofInterest
TheauthorsdeclarenoconÔ¨Çictofinterest.
Authorcontributions
Y.Z.,J.Y.,G.Z.andH.M.Z.contributedequallytothiswork.Conceptualiza-
tion:Y.Z.,J.Y.;Methodology:G.Z.,H.M.Z.;Investigation:Y.T.;Supervision:
J.L.,Q.X.;Writing‚Äìoriginaldraft:Y.Z.;Writing‚Äìreview&editing:Q.X.,Y.Z.,
J.Y.
DataAvailabilityStatement
AlldatasupportingtheÔ¨Åndingsofthisstudyareavailableinthemaintext
ortheSupportingInformationÔ¨Åles.
Keywords
3-hydroxypropionic acid, biosensor, adaptive laboratory evolution, muta-
genesis,toleranceengineering
Received:April29,2025
Revised:July20,2025
Publishedonline:August12,2025
[1] W.D.Jang,G.B.Kim,S.Y.Lee, Trends Biotechnol.2023,11,10.
[2] S.P.H.Azambuja,A.H.F.deM√©lo,B.G.Bertozzi,H.P.Inoue,V.Y.
Egawa,C.A.Rosa,L.O.Rocha,G.S.Teixeira,R.Goldbeck, FoodRes.
Int.2024,190,114637.
[3] S.Lama,E.Seol,S.Park, Metab. Eng.2020,62,116.
[4] J.Nielsen,J.D.Keasling, Cell2016,164,1185.
[5] J.M.L√≥pez,L.Duran,J.L.Avalos, Nat. Rev. Microbiol.2022,20,35.
[6] M.Sankaranarayanan,S.Ashok,S.Park, J.Ind.Microbiol.Biotechnol.
2014,41,1039.
Adv. Sci.2025,12,e07740 e07740(16of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH
www.advancedsciencenews.com www.advancedscience.com
[7] M. Yang, Y. An, H. M. Zabed, Q. Guo, J. Yun, G. Zhang, F. N. Awad,
W.Sun,X.Qi, Bioresour. Technol.2019,284,188.
[8] F. H. Lam, A. Ghader, G. R. Fink, G. Stephanopoulos,Science 2014,
346,71.
[9] E.P.Knoshaug,M.Zhang, Appl. Biochem. Biotechnol.2009,153,13.
[10] J. Yun, H. M. Zbed, Y. Zhang, G. Zhang, M. Zhao, X. Qi,Bioresour.
Technol.2022,363,127967.
[11] A.Mukhopadhyay, Trends Microbiol.2015,23,498.
[12] L.Z.Wang,M.Lu, Y.Zhang,S.Perveen, H.Zhou,Z.Wen,Z.Xu,M.
Jin,Appl. Microbiol. Biotechnol.2021,105,1745.
[13] M. M. Matson, M. M. Cepeda, A. Zhang, A. E. Case, E. S. Kavvas, X.
Wang,A.L.Carroll,I.Tagkopoulos,S.Atsumi, Metab. Eng.2022,69,
50.
[14] T.M.Conrad,N.E.Lewis,B.Palsson, Mol. Syst. Biol.2011,7,509.
[15] J. W. Drake, B. Charlesworth, D. Charlesworth, J. F. Crow,Genetics
1998,148,1667.
[16] L.Bromig,D.Weuster-Botz, Front. Bioeng. Biotechnol.2023,11,275.
[17] A. P. Jacobus, S. D. Cavassana, I. I. de Oliveira, J. A. Barreto, E.
Rohwedder, J. Frazzon, T. P. Basso, L. C. Basso, J. Gross,Biotechnol.
Biofuels Bioprod.2024,17,63.
[18] N.Guan,L.Liu, Appl. Microbiol. Biotechnol.2020,104,51.
[19] T. P. Nguyen-Vo, Y. Liang, M. Sankaranarayanan, E. Seol, A. Y. Chun,
S.Ashok,A.S.Chauhan,J.R.Kim,S.Park, Metab.Eng. 2019,53,48.
[20] X. Jian, X. Guo, J. Wang, Z. L. Tan, X. H. Xing, L. Wang, C. Zhang,
Biotechnol. Bioeng.2020,117,1724.
[21] Y.Zhang,J.Yun,G.Zhang,A.Parvez, L.Zhou,H.M.Zabed,J.Li,X.
Qi,Bioresour. Technol.2023,389,129822.
[22] Y. Zhang, J. Yun, L. Zhou, G. Zhang, M. Zhao, H. M. Zabed, X. Qi,J.
Cleaner Prod.2023,383,135524.
[23] A.H.Badran,D.R.Liu, Nat. Commun.2015,6,8425.
[24] E.Hong,J.Kim,S.J.Ha,Y.Ryu, Biotechnol. Bioprocess Eng.2015,20,
849.
[25] H.G.Lim,M.H.Noh,J.H.Jeong,S.Park,G.Y.Jung, ACSSynth.Biol.
2016,5,1247.
[26] Y. Zhong, C. Shang, H. Tao, J. Hou, Z. Cui, Q. Qi,Microb. Cell Fact.
2024,23,291.
[27] X.R.Jiang,X.Yan,L.P.Yu,X.Y.Liu,G.Q.Chen, Nat.Commun. 2021,
12,1513.
[28] E.A.Giannopoulou,M.Senda,M.P.Koentjoro,N.Adachi,N.Ogawa,
T. Senda,FEBS J.2021,288,4560.
[29] M.A.Schell, Annu. Rev. Microbiol.1993,47,597.
[30] S. Jiang, R. Wang, D. Wang, C. Zhao, Q. Ma, H. Wu, X. Xie,Metab.
Eng.2023,76,146.
[31] B. Su, P. Lai, M. R. Deng, H. Zhu,Bioresour. Technol.2024, 395,
130407.
[32] V.J.Flegler,A.Rasmussen,S.Rao,N.Wu,R.Zenobi,M.S.P.Sansom,
R. Hedrich, T. Rasmussen, B. B√∂ttcher,Proc. Natl. Acad. Sci. U.S.A.
2020,117,28754.
[33] B. B√∂ttcher, V. Prazak, A. Rasmussen, S. S. Black, T. Rasmussen,
Structure2015,23,1705.
[34] S.H.Choi,D.J.Baumler,C.W.Kaspar, Appl.Environ.Microbiol. 2000,
66,3911.
[ 3 5 ]G .B .C o l e ,T .J .B a t e m a n ,T .F .M o r a e s ,J. Biol. Chem.2021, 296,
100147.
[ 3 6 ] J .Y .S e o k ,Y .H .H a n ,J .S .Y a n g ,J .Y a n g ,H .G .L i m ,S .G .K i m ,S .W .
Seo,G.Y.Jung, Cell Rep.2021,36,109589.
[37] K.Tsuruno,H.Honjo,T.Hanai, Microb. Cell Fact.2025,14,155.
[38] B. Chen, X. Tang, Y. Zhang, H. M. Zabed, Y. Ravikumar, M. W. Iqbal,
J.Wang,M.Zhao,X.Qi, Food Biosci.2024,60,104426.
[39] K.J.Livak,T.D.Schmittgen, Methods2001,25,402.
Adv. Sci.2025,12,e07740 e07740(17of17) ¬©2025TheAuthor(s). AdvancedSciencepublishedbyWiley-VCHGmbH